act_id,struct_id,target_id,target_name,target_class,accession,gene,swissprot,act_value,act_type,act_comment,act_source,relation,moa,moa_source,act_source_url,moa_source_url,action_type,first_in_class,tdl,act_ref_id,moa_ref_id,organism
182804,3927,325,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,6.66,Ki,Competitive inhibition of binding to human placental Cytochrome P450 19A1,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
222012,5062,2068,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,6.28,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
187356,2581,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.4,IC50,Inhibition of human ERG by patch-clamp assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
162782,2253,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.0,EC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL635,AGONIST,,Tclin,,,Homo sapiens
218644,5341,542,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,7.06,Kd,Binding affinity to VEGFR2,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
222306,5280,742,Serine/threonine-protein kinase MARK2,Kinase,Q7KZI7,MARK2,MARK2_HUMAN,6.55,Kd,Binding constant for MARK2 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
163959,2666,424,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,P18031,PTPN1,PTN1_HUMAN,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
185001,1045,2276,"Interferon-induced, double-stranded RNA-activated protein kinase",Kinase,P19525,EIF2AK2,E2AK2_HUMAN,5.89,Kd,Binding constant for PRKR kinase domain,CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
26581,3643,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,4.8,Kd,,IUPHAR,=,,,,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
187505,4134,118,Aldehyde oxidase,Enzyme,Q06278,AOX1,AOXA_HUMAN,4.52,Ki,Tested for its ability to inhibit rabbit liver aldehyde oxidase catalyzed oxidation of N-methyl-nicotinamide (NMN),CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
219698,1285,4574,CDGSH iron-sulfur domain-containing protein 1,Unclassified,Q9NZ45,CISD1,CISD1_HUMAN,5.14,Ki,Displacement of [3H]rosiglitazone from recombinant human C-terminal His-tagged MitoNEET cytosolic domain (32 to 108 residues) expressed in Escherichia coli BL21 by Cheng-Prusoff analysis,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
185018,1045,52,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,6.15,Kd,Binding constant for JAK3(JH1domain-catalytic) kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
26516,2470,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.5,Ki,,IUPHAR,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
221429,5495,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,8.59,IC50,Radiometric filter binding assay,DRUG LABEL,=,1.0,DRUG LABEL,"https://www.accessdata.fda.gov/drugsatfda_docs/nda/2021/215358Orig1s000,Orig2s000MultidisciplineR.pdf",https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215358s000Orig2lbl.pdf,INHIBITOR,,Tclin,3274.0,3273.0,Homo sapiens
215524,4381,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,8.95,IC50,Inhibition of the reuptake of [<sup>3</sup>H]5-HT,IUPHAR,=,1.0,IUPHAR,,http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7901,INHIBITOR,,Tclin,,,Homo sapiens
184283,1227,667,Bile acid receptor,Nuclear hormone receptor,Q96RI1,NR1H4,NR1H4_HUMAN,4.86,IC50,Antagonist activity at human GTS-tagged FXR after 20 mins by TR-FRET assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
183763,949,2472,Astrosclerin-3,Enzyme,A6YCJ1,,A6YCJ1_9METZ,6.55,Ki,Inhibition of GST-tagged astrosclera willeyana Astrosclerin-3 expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay,CHEMBL,=,,,,,,,,,,Astrosclera willeyana
37650,2561,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.877,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
220253,5426,2137,Non-receptor tyrosine-protein kinase TYK2,Kinase,P29597,TYK2,TYK2_HUMAN,7.24,IC50,ATP concentration at the Km specific for Tyk2 of 40 Î¼M,SCIENTIFIC LITERATURE,=,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/25387665,https://pubmed.ncbi.nlm.nih.gov/25387665,INHIBITOR,,Tclin,3057.0,3057.0,Homo sapiens
218245,5327,669,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,8.523,IC50,Mechanism of Action,SCIENTIFIC LITERATURE,=,1.0,DRUG LABEL,https://pubmed.ncbi.nlm.nih.gov/31161538,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212018s000lbl.pdf,INHIBITOR,,Tclin,2588.0,2587.0,Homo sapiens
222512,4654,2168,Mitogen-activated protein kinase kinase kinase MLT,Kinase,Q9NYL2,ZAK,MLTK_HUMAN,6.56,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
215672,2105,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,5.98,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
216965,138,3271,Cation channel sperm-associated protein 2,Ion channel,Q96P56,CATSPER2,CTSR2_HUMAN,6.3,EC50,Patch clamp electrophysiology.,IUPHAR,=,,,,,ACTIVATOR,,Tchem,,,Homo sapiens
187800,4187,2354,Serine/threonine-protein kinase TAO3,Kinase,Q9H2K8,TAOK3,TAOK3_HUMAN,6.31,Kd,Binding constant for TAOK3 kinase domain,CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
219092,5311,3989,Beta-3 adrenergic receptor,GPCR,P26255,Adrb3,ADRB3_RAT,7.07,EC50,Agonist activity at rat beta3 adrenergic receptor expressed in CHO cells assessed as accumulation of cAMP after 30 mins by TR-FRET assay,CHEMBL,=,,,,,,,,,,Rattus norvegicus
33888,249,1716,Melanocortin receptor 4,GPCR,P32245,MC4R,MC4R_HUMAN,4.87,Ki,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
164709,2326,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
164730,888,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
220456,5457,5130,Complement C3,Unclassified,P01024,C3,CO3_HUMAN,6.6,IC50,MoA - inhibition of complement activation evaluated in ELISA assay,SCIENTIFIC LITERATURE,=,1.0,DRUG LABEL,https://pubmed.ncbi.nlm.nih.gov/24497537,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215014s000lbl.pdf,INHIBITOR,,Tbio,3221.0,3220.0,Homo sapiens
34049,431,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,8.399,Ki,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201237,ANTAGONIST,,Tclin,,,Homo sapiens
186715,785,2461,Dual specificity mitogen-activated protein kinase kinase 5,Kinase,Q13163,MAP2K5,MP2K5_HUMAN,8.48,Kd,Binding constant for MEK5 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
181289,1624,2580,Carbonic anhydrase 2,Enzyme,P9WPJ9,mtcA2,MTCA2_MYCTU,4.51,Ki,Inhibition of full length Mycobacterium tuberculosis H37Rv recombinant carbonic anhydrase 2 encoded by RV3588c by stopped flow CO2 hydration assay,CHEMBL,=,,,,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
183861,1912,2426,Signal transducer and activator of transcription 3,Transcription factor,P40763,STAT3,STAT3_HUMAN,6.6,IC50,Inhibition of STAT3 in human HeLa cells after 24 hrs by luciferase reporter gene assay,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
215535,5154,3723,Genome polyprotein,Polyprotein,Q5I2N3,,POLG_HCV6A,11.097,EC50,,DRUG LABEL,=,1.0,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf,INHIBITOR,,,613.0,613.0,Hepatitis C virus genotype 6a (isolate 6a33) (HCV)
223515,1231,314,Aldose reductase,Enzyme,P15121,AKR1B1,ALDR_HUMAN,4.28,IC50,"Inhibition of recombinant human ALR2 using D,L-glyceraldehyde and NADPH as substrate preincubated for 3 mins followed by substrate addition and measured for 3 mins by spectrophotometric analysis",CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
222356,5289,905,Mitogen-activated protein kinase 9,Kinase,P45984,MAPK9,MK09_HUMAN,6.04,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
35590,1103,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.577,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
219453,1751,1124,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,P13922,,DRTS_PLAFK,7.08,IC50,Inhibition of Plasmodium falciparum DHFR,CHEMBL,=,,,,,,,,,,Plasmodium falciparum
162971,1353,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.0,Ki,,WOMBAT-PK,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
224101,2553,3504,Nuclear receptor subfamily 2 group E member 1,Nuclear hormone receptor,Q9Y466,NR2E1,NR2E1_HUMAN,5.3,EC50,Agonist activity at in human TLX LBD expressed in human HEK293T cells coexpressing Gal4-VP 16 assessed as increase in reporter activity measured after 14 hrs by luciferase reporter gene assay relative to control,CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
217719,5231,2178,NT-3 growth factor receptor,Kinase,Q16288,NTRK3,NTRK3_HUMAN,5.77,Kd,Binding constant for TRKC kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
37567,2525,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,4.533,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
223771,2714,4926,Transient receptor potential cation channel subfamily V member 2,Ion channel,Q9Y5S1,TRPV2,TRPV2_HUMAN,5.0,IC50,,IUPHAR,=,,,,,BLOCKER,,Tchem,,,Homo sapiens
221003,2146,5253,Alpha-1B adrenergic receptor,GPCR,G3HDX1,,G3HDX1_CRIGR,8.0,EC50,Agonist activity at hamster recombinant alpha-1B receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay,CHEMBL,=,,,,,,,,,,Cricetulus griseus
222051,4716,839,Tyrosine-protein kinase Fgr,Kinase,P09769,FGR,FGR_HUMAN,7.42,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
164637,1824,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.84,Ki,,WOMBAT-PK,=,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/1354949,ANTAGONIST,,Tclin,,486.0,Homo sapiens
163855,2561,2493,Solute carrier family 22 member 2,Transporter,O15244,SLC22A2,S22A2_HUMAN,4.061,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
3467,1497,229,Catalase-peroxidase,Enzyme,P9WIE4,katG,KATG_MYCTO,,,,WOMBAT-PK,,,,,,,,,,,Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh)
185130,2339,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2b|Adra2c|Adra2a,ADA2B_RAT|ADA2C_RAT|ADA2A_RAT,5.25,IC50,In vitro inhibitory activity against alpha-2 adrenergic receptor from rat brain minus cerebellum using [3H]clonidine as radioligand,CHEMBL,=,,,,,,,,,,Rattus norvegicus
215693,1891,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.773,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
222945,4914,2576,Protein cereblon,Cytosolic other,Q96SW2,CRBN,CRBN_HUMAN,5.33,Ki,Binding affinity to human CRBN-thalidomide binding domain expressed in Escherichia coli by measuring baseline corrected normalized fluorescence by MST based assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
223744,5740,3515,Complement C5,Secreted,P01031,C5,CO5_HUMAN,,,Mechanism of Action,UNKNOWN,=,1.0,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761339s000lbl.pdf,INHIBITOR,,Tclin,,3700.0,Homo sapiens
218929,5347,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,7.42,Kd,Binding constant for FYN kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
186175,1282,839,Tyrosine-protein kinase Fgr,Kinase,P09769,FGR,FGR_HUMAN,5.59,Kd,Binding constant for FGR kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
222994,2611,5390,Alpha-synuclein,Transporter,P37840,SNCA,SYUA_HUMAN,5.22,IC50,Inhibition of alpha-synuclein fibril formation (unknown origin) incubated for 24 hrs to 7 days by thioflavin S based fluorescence assay,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
182872,1992,1855,5-hydroxytryptamine receptor 4,GPCR,Q62758,Htr4,5HT4R_RAT,5.92,Ki,The binding affinity was measured on 5-hydroxytryptamine 4 receptor using [3H]- GR-113808 as radioligand.,CHEMBL,=,,,,,,,,,,Rattus norvegicus
37419,2391,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,7.796,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
216376,885,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,8.58,IC50,,CHEMBL,=,,,,,,,,,,Rattus norvegicus
181000,947,1814,D(2) dopamine receptor,GPCR,P20288,DRD2,DRD2_BOVIN,8.74,Ki,Binding Affinity on high Affinity Site of Bovine dopamine receptor D2. Tested for ability to displace the radioligand [3H]pramipexole was tested,CHEMBL,=,,,,,,,,,,Bos taurus
164601,1816,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
170607,201,877,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",Enzyme,Q13370,PDE3B,PDE3B_HUMAN,4.51,IC50,,IUPHAR,=,,,,,INHIBITOR,,Tclin,,,Homo sapiens
181498,1809,1890,Cyclic nucleotide phosphodiesterase PDE3A,Enzyme,Q9XSW7,,Q9XSW7_PIG,6.07,IC50,"Inhibition of phosphodiesterase 3 (PDE3) from porcine platelets, range 0.581-1.23",CHEMBL,=,,,,,,,,,,Sus scrofa
163161,1794,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,4.53,IC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL146855,BLOCKER,,Tclin,,,Homo sapiens
162851,1129,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,7.93,Kd,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL902,ANTAGONIST,,Tclin,,,Homo sapiens
38428,4425,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,6.018,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
162760,427,135,Solute carrier family 12 member 1,Transporter,Q13621,SLC12A1,S12A1_HUMAN,7.6,Ki,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1072,INHIBITOR,,Tclin,,,Homo sapiens
34236,621,1718,Melanocortin receptor 3,GPCR,P41968,MC3R,MC3R_HUMAN,4.673,Ki,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
180642,4966,3512,Interleukin-12,Cytokine,P29459|P29460,IL12A|IL12B,IL12A_HUMAN|IL12B_HUMAN,,,Mechanism of Action,DRUG LABEL,,1.0,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125261s114lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125261s114lbl.pdf,ANTIBODY BINDING,1.0,Tclin|Tclin|Tclin|Tclin,228.0,228.0,Homo sapiens
27220,2717,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,6.975,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
183409,1780,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,,,Mechanism of Action; CHEMBL225; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201342,ANTAGONIST,,Tclin,,,Homo sapiens
163465,928,81,Translocator protein,Transporter,P30536,TSPO,TSPO_HUMAN,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
215534,5154,3722,Genome polyprotein,Polyprotein,O91936,,POLG_HCVSA,10.426,EC50,,DRUG LABEL,=,1.0,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/208341s000lbl.pdf,INHIBITOR,,,613.0,613.0,Hepatitis C virus genotype 5a (isolate SA13) (HCV)
187741,4187,2202,Serine/threonine-protein kinase TNNI3K,Kinase,Q59H18,TNNI3K,TNI3K_HUMAN,6.96,Kd,Binding constant for TNNI3K kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
187970,4207,3494,Inositol-1(or 4)-monophosphatase 1,Enzyme,P29218,IMPA1,IMPA1_HUMAN,,,Mechanism of Action; CHEMBL1786; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200826,INHIBITOR,,Tclin,,,Homo sapiens
221727,4190,2240,Mitogen-activated protein kinase kinase kinase 11,Kinase,Q16584,MAP3K11,M3K11_HUMAN,5.72,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
185845,1610,1805,Type-2 angiotensin II receptor,GPCR,P35351,Agtr2,AGTR2_RAT,5.13,IC50,"In vitro inhibitory activity against Angiotensin II receptor, type 2 in rat midbrain membrane preparations.",CHEMBL,=,,,,,,,,,,Rattus norvegicus
181322,1015,147,Adenosine receptor A2b,GPCR,P29275,ADORA2B,AA2BR_HUMAN,5.33,Ki,"Binding affinity at human Adenosine A2B receptor expressed in HEK293 cells, using [125I]ABOPX as radioligand",CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
188189,4304,2060,Sodium/glucose cotransporter 2,Transporter,P53792,Slc5a2,SC5A2_RAT,8.52,EC50,Inhibition of rat SGLT2 expressed in CHO cells assessed as inhibition of [14C]AMG accumulation,CHEMBL,=,,,,,,,,,,Rattus norvegicus
163730,1774,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRG2|GABRB3,GBRA1_HUMAN|GBRG2_HUMAN|GBRB3_HUMAN,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200790,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
219528,2080,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,6.0,Ki,Displacement of [3H]N-methylspiperone from human dopamine D4 receptor by radioligand binding assay,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
222906,5288,5467,Heat sensitive channel TRPV3,Unclassified,Q4QYD9,,Q4QYD9_RAT,6.29,EC50,Agonist activity at rat TRPV3 stably transfected in HEK293 cells assessed as increase in calcium influx in presence of ionomycin by Fluo-4-AM dye based spectrofluorimetric method,CHEMBL,=,,,,,,,,,,Rattus norvegicus
172501,4941,2322,Cyclin-dependent kinase 4,Kinase,P11802,CDK4,CDK4_HUMAN,7.959,IC50,Cdk4/cyclin D1,SCIENTIFIC LITERATURE,=,1.0,DRUG LABEL,https://pubmed.ncbi.nlm.nih.gov/15542782,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207103s000lbl.pdf,INHIBITOR,,Tclin,171.0,170.0,Homo sapiens
164597,2014,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.13,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
181636,56,2579,Delta carbonic anhydrase,Unclassified,Q5U9J1,ca1,Q5U9J1_THAWE,7.08,Ki,Inhibition of Thalassiosira weissflogii delta carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,,,,,,,,Thalassiosira weissflogii
180927,488,2583,Acetylcholine receptor subunit alpha,Ion channel,P02710,CHRNA1,ACHA_TORCA,5.12,IC50,Displacement of [3H]alpha-BGT from nAChR in Torpedo nobiliana electric organs,CHEMBL,=,,,,,,,,,,Torpedo californica
221146,1164,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.34,IC50,Inhibition of human OCT1 expressed in HEK293 cells assessed as reduction in ASP+ substrate uptake by microplate reader based analysis,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
186320,2459,532,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.41,IC50,Inhibition of recombinant c-Src by radioactive phosphotransfer assay in presence of 10 uM ATP,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
187610,4178,808,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,5.96,Kd,Binding constant for FGFR2 kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
25792,1775,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.8,Ki,,IUPHAR,=,,,,,ANTAGONIST,,Tchem,,,Homo sapiens
33898,260,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.276,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
27759,1524,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.701,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
183176,3514,1788,Alcohol dehydrogenase [NADP(+)],Enzyme,P51635,Akr1a1,AK1A1_RAT,5.63,IC50,In vitro inhibitory activity against aldehyde reductase 1 (ALR1) from rat kidney.,CHEMBL,=,,,,,,,,,,Rattus norvegicus
187955,4190,2229,Dual specificity mitogen-activated protein kinase kinase 4,Kinase,P45985,MAP2K4,MP2K4_HUMAN,5.74,Kd,Binding constant for MEK4 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
28126,242,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.421,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
36267,1723,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.678,Ki,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
172035,374,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,8.62,Kd,,IUPHAR,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
215582,1980,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,7.921,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
186345,2459,538,Serine/threonine-protein kinase B-raf,Kinase,P15056,BRAF,BRAF_HUMAN,7.66,Ki,Inhibition of B-Raf,CHEMBL,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1336,INHIBITOR,1.0,Tclin,,,Homo sapiens
216431,2717,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.65,Ki,,CHEMBL,=,,,,,,,,,,Rattus norvegicus
215081,5091,3698,T-lymphocyte activation antigen CD80,Surface antigen,P33681,CD80,CD80_HUMAN,,,Mechanism of Action,DRUG LABEL,,1.0,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/125288s062lbl.pdf,INHIBITOR,,Tclin,,575.0,Homo sapiens
33932,313,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.068,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
181526,2872,2405,Carbonic anhydrase,Enzyme,C0IX24,CA2,C0IX24_9CNID,6.19,Ki,Inhibition of Stylophora pistillata carbonic anhydrase 2 by stopped-flow CO2 hydration assay,CHEMBL,=,,,,,,,,,,Stylophora pistillata
164997,2652,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.9,IC50,,WOMBAT-PK,=,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/6782492,INHIBITOR,,Tclin,,214.0,Homo sapiens
164584,951,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,6.963,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
218886,5347,2463,Myosin light chain kinase 3,Kinase,Q32MK0,MYLK3,MYLK3_HUMAN,5.01,Kd,Binding constant for MLCK kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
163242,489,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRG2|GABRB2,GBRA1_HUMAN|GBRG2_HUMAN|GBRB2_HUMAN,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
220232,5423,746,Cytoplasmic tyrosine-protein kinase BMX,Kinase,P51813,BMX,BMX_HUMAN,8.22,IC50,,SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/31953125,,INHIBITOR,,Tchem,3051.0,,Homo sapiens
184918,3584,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.75,IC50,Inhibition of human ERG,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
164528,1475,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,8.77,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
223727,5724,4398,Histone-lysine N-methyltransferase EZH1,Enzyme,Q92800,EZH1,EZH1_HUMAN,8.0,IC50,Cell-free enzymatic assays; possible Mechanism of Action target,SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/36380144,,INHIBITOR,,Tchem,3681.0,,Homo sapiens
180749,1745,3520,Dopamine beta-hydroxylase,Enzyme,P15101,DBH,DOPO_BOVIN,4.35,Ki,Compound was evaluated for the inhibition of Dopamine beta hydroxylase at pH 4.5,CHEMBL,=,,,,,,,,,,Bos taurus
180765,1334,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,4.22,Ki,Inhibition of human erythrocyte CA1 esterase activity using 4-nitrophenyl acetate substrate,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
219311,4109,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.99,EC50,Agonist activity at recombinant human CB1 receptor expressed in CHO-K1 cells assessed as increase in cAMP accumulation after 20 mins by HTRF assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
220597,4156,5391,Polyunsaturated fatty acid lipoxygenase ALOX15,Enzyme,P39654,Alox15,LOX15_MOUSE,4.47,IC50,Inhibition of 15-LOX-mediated lipid oxidation in 10% C57BL/6J mouse plasma,CHEMBL,=,,,,,,,,,,Mus musculus
171881,1588,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,8.3,Ki,,IUPHAR,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
164018,1422,340,Prostaglandin E2 receptor EP3 subtype,GPCR,P43115,PTGER3,PE2R3_HUMAN,7.3,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
37151,2284,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.377,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
94089,547,632,Catechol O-methyltransferase,Enzyme,P21964,COMT,COMT_HUMAN,4.85,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
186840,1580,2875,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P04774|P04775|P08104,Scn1a|Scn2a|Scn3a,SCN1A_RAT|SCN2A_RAT|SCN3A_RAT,7.11,Ki,Inhibition of [3H]- batrachotoxin binding to sodium channel in rat neocortical membrane,CHEMBL,=,,,,,,,,,,Rattus norvegicus
218171,5302,2212,Leukocyte tyrosine kinase receptor,Kinase,P29376,LTK,LTK_HUMAN,8.569,IC50,,SCIENTIFIC LITERATURE,=,1.0,DRUG LABEL,https://pubmed.ncbi.nlm.nih.gov/25733882,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf,INHIBITOR,,Tclin,2538.0,2535.0,Homo sapiens
219175,2291,397,Potassium channel subfamily K member 2,Ion channel,O95069,KCNK2,KCNK2_HUMAN,5.12,IC50,Inhibition of of human TREK1 expressed in CHO cells assessed as reduction in channel currents,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
170939,4122,1683,Transient receptor potential cation channel subfamily A member 1,Ion channel,O75762,TRPA1,TRPA1_HUMAN,6.0,EC50,Calcium imaging,IUPHAR,=,,,,,ACTIVATOR,,Tclin,,,Homo sapiens
185291,2544,903,MAP kinase-interacting serine/threonine-protein kinase 2,Kinase,Q9HBH9,MKNK2,MKNK2_HUMAN,5.24,Kd,Binding constant for MKNK2 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
182990,725,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprm1|Oprk1|Sigmar1,OPRD_RAT|OPRM_RAT|OPRK_RAT|SGMR1_RAT,8.0,IC50,50% Inhibition of stereospecific [3H]-naltrexone (10e-9 M) binding towards opiate receptor in rat brain homogenate,CHEMBL,=,,,,,,,,,,Rattus norvegicus
187469,2997,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,8.22,IC50,Inhibition of binding of [3H]-naloxone to Opioid receptor mu 1 of rat brain membranes,CHEMBL,=,,,,,,,,,,Rattus norvegicus
166114,1863,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,3.34,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164374,2274,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.17,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
182565,2387,344,Farnesyl pyrophosphate synthase,Enzyme,P14324,FDPS,FPPS_HUMAN,9.44,Ki,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,CHEMBL,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL923,INHIBITOR,,Tclin,,,Homo sapiens
182231,1816,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1b|Adra1d|Adra1a,ADA1B_RAT|ADA1D_RAT|ADA1A_RAT,6.22,Ki,Inhibition of [3H]prazosin binding to rat Alpha-1 adrenergic receptor,CHEMBL,=,,,,,,,,,,Rattus norvegicus
181262,1009,1692,Potassium channel subfamily K member 18,Ion channel,Q7Z418,KCNK18,KCNKI_HUMAN,,,Mechanism of Action; CHEMBL2331042; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1257,OPENER,,Tclin,,,Homo sapiens
183261,723,1775,Transporter,Transporter,Q9WTR4,Slc6a2,Q9WTR4_RAT,6.97,Ki,Inhibition of high affinity uptake of [3H]NE by norepinephrine transporter in nerve endings obtained from rat brain.,CHEMBL,=,,,,,,,,,,Rattus norvegicus
219433,1821,2282,Proto-oncogene tyrosine-protein kinase ROS,Kinase,P08922,ROS1,ROS1_HUMAN,5.52,IC50,"Inhibition of ROS1 (unknown origin) using poly (Glu,Tyr)4:1 substrate and ATP incubated for 60 mins by ELISA",CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
187446,2966,1743,Reverse transcriptase/RNaseH,Enzyme,Q72547,pol,Q72547_9HIV1,5.03,IC50,Inhibition of purified HIV-1 reverse transcriptase,CHEMBL,=,,,,,,,,,,Human immunodeficiency virus 1
190868,1195,3533,GABA-A receptor; anion channel,Ion channel,O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABRP|GABRD|GABRA1|GABRB1|GABRG2|GABRB3|GABRA5|GABRA3|GABRA2|GABRB2|GABRA4|GABRE|GABRA6|GABRG1|GABRG3|GABRQ,GBRP_HUMAN|GBRD_HUMAN|GBRA1_HUMAN|GBRB1_HUMAN|GBRG2_HUMAN|GBRB3_HUMAN|GBRA5_HUMAN|GBRA3_HUMAN|GBRA2_HUMAN|GBRB2_HUMAN|GBRA4_HUMAN|GBRE_HUMAN|GBRA6_HUMAN|GBRG1_HUMAN|GBRG3_HUMAN|GBRT_HUMAN,9.05,Ki,Displacement of [3H]flumazenil from bovine benzodiazepine receptor GABA-A channel of brain membranes,CHEMBL,=,,,,,,,Tclin|Tbio|Tchem|NA,,,Homo sapiens
219415,4223,1791,Acetylcholinesterase,Enzyme,P37136,Ache,ACES_RAT,4.67,IC50,Inhibition of rat cortex AChE using acetylthiocholine iodide as substrate after 20 mins by by Ellman's method,CHEMBL,=,,,,,,,,,,Rattus norvegicus
187539,4172,2377,Cathepsin K,Enzyme,P43235,CTSK,CATK_HUMAN,7.4,IC50,Inhibition of human Cathepsin K,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
38476,4733,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.699,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
181430,2621,2750,Tubulin,Structural,C4PKY4|C4PKZ2|C4PKZ6,,C4PKY4_ECHGR|C4PKZ2_ECHGR|C4PKZ6_ECHGR,,,Mechanism of Action; CHEMBL2364704; PROTEIN COMPLEX GROUP,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL625,INHIBITOR,,,,,Echinococcus granulosus
217737,5231,674,Tyrosine-protein kinase HCK,Kinase,P08631,HCK,HCK_HUMAN,6.14,Kd,Binding constant for HCK kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
164351,1385,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.9,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
222264,5280,2213,Mitogen-activated protein kinase kinase kinase kinase 1,Kinase,Q92918,MAP4K1,M4K1_HUMAN,5.85,Kd,Binding constant for HPK1 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
182276,90,2839,Adenosine A2 receptor,GPCR,P29276|P30543,Adora2b|Adora2a,AA2BR_RAT|AA2AR_RAT,8.3,Ki,Binding affinity for Adenosine A2 receptor in corpora striata of rats using [3H]NECA,CHEMBL,=,,,,,,,,,,Rattus norvegicus
185094,2817,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.96,IC50,Inhibition of human Potassium channel HERG expressed in mammalian cells,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
187098,1527,3620,Cytochrome P450 51,Enzyme,Q64654,Cyp51a1,CP51A_RAT,7.19,Ki,Inhibition of lanosterol 14-alpha-demethylase of rat hepatic microsomes,CHEMBL,=,,,,,,,,,,Rattus norvegicus
222286,4866,2283,Ribosomal protein S6 kinase alpha-1,Kinase,Q15418,RPS6KA1,KS6A1_HUMAN,4.67,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
219278,647,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,7.3,IC50,"Inhibition Assay: Incubations were conducted in 96 well microtiter plates based on a method described by BD Biosciences. To the first well in each row, a NADPH regenerating system and test compound was added. In the second well and all remaining wells, NADPH regenerating system and acetonitrile (final concentration of 2%) was added. The final assay concentration of the NADPH regenerating system was 8.2 uM NADP+, 0.41 mM glucose-6-phosphate, 0.41 mM magnesium chloride hexahydrate and 0.4 U/ml glucose-6-phosphate dehydrogenase and 0.01 mg/mL control insect cell membrane protein. The test compound solution was serially diluted 1:3 through the eighth wells.The final concentration of the test compounds were in the range 100 uM to 45.7 nM in the eight rows. Wells 9 and 10 contained no test compound (only NADPH regenerating system and enzyme/substrate mix) and wells 11 and 12 were used as controls for background fluorescence (enzyme and substrate were added after the reaction was te",CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
217059,1086,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.51,Ki,Displacement of [<sup<3</sup>H]QNB binding in rat forebrain brain homogenate.,IUPHAR,=,,,,,ANTAGONIST,,,,,Rattus norvegicus
164885,1805,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.64,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
37174,2286,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.376,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
34014,402,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,7.444,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
183485,191,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,6.3,Ki,Binding affinity towards human 5-hydroxytryptamine 7 receptor,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
181770,2492,1963,Beta-lactamase,Enzyme,P24735,ampC,AMPC_PSEAE,4.57,IC50,Inhibition of Pseudomonas aeruginosa beta-lactamase AmpC assessed as nitrocefin hydrolysis after 5 mins enzyme-compound preincubation,CHEMBL,=,,,,,,,,,,Pseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228)
219071,2706,4130,"Carbonic anhydrase, alpha family",Unclassified,Q31FD6,,Q31FD6_HYDCU,6.11,Ki,Inhibition of recombinant Thiomicrospira crunogena XCL-2 carbonic anhydrase by stopped flow CO2 hydrase assay,CHEMBL,=,,,,,,,,,,Hydrogenovibrio crunogenus (strain XCL-2)
214996,2152,142,Sodium channel protein type 9 subunit alpha,Ion channel,Q15858,SCN9A,SCN9A_HUMAN,,,Mechanism of Action,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16,BLOCKER,,Tclin,,,Homo sapiens
26999,3170,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.1,Kd,,IUPHAR,=,,,,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
221749,5280,53,Macrophage-stimulating protein receptor,Kinase,Q04912,MST1R,RON_HUMAN,6.33,Kd,Binding constant for MST1R kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
36507,1800,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,7.796,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
217028,888,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,6.8,Ki,,IUPHAR,=,,,,,ANTAGONIST,,,,,Rattus norvegicus
181450,874,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,,,Mechanism of Action; CHEMBL222; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1194666,INHIBITOR,,Tclin,,,Homo sapiens
187050,1932,2202,Serine/threonine-protein kinase TNNI3K,Kinase,Q59H18,TNNI3K,TNI3K_HUMAN,6.44,Kd,Binding constant for TNNI3K kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
218374,5342,4360,Beta-lactamase,Enzyme,Q93DC4,bla,Q93DC4_KLEPN,6.59,IC50,,SCIENTIFIC LITERATURE,=,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/31383664,https://pubmed.ncbi.nlm.nih.gov/31383664,INHIBITOR,,,2706.0,2706.0,Klebsiella pneumoniae
186201,1282,802,Ephrin type-A receptor 5,Kinase,P54756,EPHA5,EPHA5_HUMAN,5.82,Kd,Binding constant for EPHA5 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
183597,703,2777,GABA-A receptor; anion channel,Ion channel,P08219|P08220|P10063|P10064|P20237|P22300,GABRA1|GABRB1|GABRA2|GABRA3|GABRA4|GABRG2,GBRA1_BOVIN|GBRB1_BOVIN|GBRA2_BOVIN|GBRA3_BOVIN|GBRA4_BOVIN|GBRG2_BOVIN,9.07,Ki,In vitro inhibition of [3H]-Ro- 15-1788 binding to GABA-A Benzodiazepine receptor of bovine brain membranes,CHEMBL,=,,,,,,,,,,Bos taurus
221926,5280,846,Aurora kinase A,Kinase,O14965,AURKA,AURKA_HUMAN,7.53,Kd,Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
36170,1634,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.845,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
187784,4187,966,Activin receptor type-1,Kinase,Q04771,ACVR1,ACVR1_HUMAN,6.36,Kd,Binding constant for ACVR1 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
162421,3862,413,Retinoic acid receptor RXR-alpha,Nuclear hormone receptor,P19793,RXRA,RXRA_HUMAN,6.5,EC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705,AGONIST,,Tclin,,,Homo sapiens
164061,1215,303,Potassium voltage-gated channel subfamily KQT member 3,Ion channel,O43525,KCNQ3,KCNQ3_HUMAN,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
216855,318,3819,M1-family alanyl aminopeptidase,Enzyme,Q8IEK1,,Q8IEK1_PLAF7,4.2,IC50,Active,CHEMBL,=,,,,,,,,,,Plasmodium falciparum (isolate 3D7)
184971,2797,667,Bile acid receptor,Nuclear hormone receptor,Q96RI1,NR1H4,NR1H4_HUMAN,,,Mechanism of Action; CHEMBL2047; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1551,AGONIST,,Tclin,,,Homo sapiens
188398,4359,1317,Dual specificity mitogen-activated protein kinase kinase 7,Kinase,O14733,MAP2K7,MP2K7_HUMAN,5.28,Kd,Binding constant for MKK7 kinase domain,CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
34232,621,1716,Melanocortin receptor 4,GPCR,P32245,MC4R,MC4R_HUMAN,4.835,Ki,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35433,1028,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.559,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679,AGONIST,,Tclin,,,Homo sapiens
219326,1331,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,5.14,IC50,Inhibition of human OCT1 expressed in HEK293 cells assessed as decrease in uptake of ASP+ after 2 mins by fluorescence assay,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
163565,158,89,Adenosine receptor A2a,GPCR,P29274,ADORA2A,AA2AR_HUMAN,5.48,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
187620,4178,824,TRAF2 and NCK-interacting protein kinase,Kinase,Q9UKE5,TNIK,TNIK_HUMAN,5.64,Kd,Binding constant for TNIK kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
181247,1494,2041,Lysosomal protective protein,Enzyme,P10619,CTSA,PPGB_HUMAN,5.0,IC50,Inhibition of recombinant CatA using [14C]GS-7340 substrate,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
36630,1848,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,6.0,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
163972,2422,403,Gag-Pol polyprotein,Polyprotein,P03367,gag-pol,POL_HV1BR,10.187,Ki,,WOMBAT-PK,=,,,,,,,,,,Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI)
142197,4908,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,5.523,IC50,recombinant human AChE,DRUG LABEL,=,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/21651906,INHIBITOR,,Tclin,,285.0,Homo sapiens
37332,2338,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,5.724,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
163981,1446,388,"DNA topoisomerase I, mitochondrial",Enzyme,Q969P6,TOP1MT,TOP1M_HUMAN,6.52,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
184932,581,735,Angiopoietin-1 receptor,Kinase,Q02763,TEK,TIE2_HUMAN,4.05,Kd,Binding affinity to human recombinant Tie2 by SPR assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
180901,65,2724,Neuronal acetylcholine receptor; alpha2/beta2,Ion channel,P12389|P12390,Chrna2|Chrnb2,ACHA2_RAT|ACHB2_RAT,7.96,Ki,Binding affinity towards rat nicotinic acetylcholine receptor alpha2-beta2 expressed in HEK293 cells using [3H]EB as radioligand,CHEMBL,=,,,,,,,,,,Rattus norvegicus
164443,2172,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.424,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
182546,3652,1745,Muscarinic acetylcholine receptor M1,GPCR,P08482,Chrm1,ACM1_RAT,8.7,IC50,Binding affinity for muscarinic acetylcholine receptor M1 using [3H]oxotremorine-M (Oxo-M) radioligand in rat hippocampus membranes,CHEMBL,=,,,,,,,,,,Rattus norvegicus
223510,4112,6043,"NACHT, LRR and PYD domains-containing protein 3",Unclassified,Q8R4B8,Nlrp3,NLRP3_MOUSE,5.17,IC50,Inhibition of NLRP3 inflammasome in LPS-primed mouse J774.A1 cells assessed as reduction in IL-1beta secretion preincubated with compound for 1 hr followed by nigericin stimulation for 1 hr by ELISA,CHEMBL,=,,,,,,,,,,Mus musculus
181542,2872,1816,Amine oxidase [flavin-containing] B,Enzyme,P19643,Maob,AOFB_RAT,5.54,Ki,Competitive inhibition of rat MAO B by spectrophotometry,CHEMBL,=,,,,,,,,,,Rattus norvegicus
184720,1353,2866,Serotonin 2 (5-HT2) receptor,GPCR,P34968|P35363|Q02152,Htr2c|Htr2a|Htr2b,5HT2C_MOUSE|5HT2A_MOUSE|5HT2B_MOUSE,7.58,Ki,Binding affinity against 5-hydroxytryptamine 2 receptor from rat cortical synaptosomal membrane using radioligand [3H]ketanserin.,CHEMBL,=,,,,,,,,,,Mus musculus
181581,611,3432,"Arachidonate 15-lipoxygenase, type II",Enzyme,O15296,ALOX15B,LX15B_HUMAN,4.55,IC50,Inhibition of human reticulocyte N-terminally His6-tagged 15-lipoxygenase-2 assessed as conjugated diene product formation using arachidonic acid by UV-vis spectrophotometer analysis,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
188156,4265,241,Dihydrofolate reductase,Enzyme,P00374,DHFR,DYR_HUMAN,4.74,IC50,Inhibition of human DHFR after 2 mins,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
218892,5347,540,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,7.32,IC50,Inhibition of RET (unknown origin),CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
189292,999,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.886,Ki,Mechanism of Action,DRUG LABEL,=,1.0,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20706slr011_emadine_lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20706slr011_emadine_lbl.pdf,ANTAGONIST,,Tclin,457.0,457.0,Homo sapiens
183204,3514,2558,Malate dehydrogenase,Enzyme,P10584,mdh,MDH_THETH,5.22,IC50,Inhibitory activity against malate dehydrogenase (MDH) from Thermus flavus,CHEMBL,=,,,,,,,,,,Thermus thermophilus
186729,785,2352,Mitogen-activated protein kinase kinase kinase 7,Kinase,O43318,MAP3K7,M3K7_HUMAN,5.43,Kd,Binding constant for TAK1 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
220643,5459,744,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,5.52,IC50,Inhibition of MET-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
183517,2799,2009,Carbonic anhydrase,Enzyme,P40881,,CAH_METTE,6.89,Ki,Inhibitory activity against alpha carbonic anhydrase (Zn-Cam) from Methanosarcina thermophila,CHEMBL,=,,,,,,,,,,Methanosarcina thermophila
188884,4903,2447,Serine/threonine-protein kinase SBK1,Kinase,Q52WX2,SBK1,SBK1_HUMAN,6.96,Kd,Binding constant for SBK1 kinase domain,CHEMBL,=,,,,,,,Tdark,,,Homo sapiens
221545,5502,361,Hydroxycarboxylic acid receptor 2,GPCR,Q8TDS4,HCAR2,HCAR2_HUMAN,6.74,Ki,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
220227,5421,930,Egl nine homolog 1,Enzyme,Q9GZT9,EGLN1,EGLN1_HUMAN,8.46,IC50,FRET assay developed to measure human PHD enzymatic activity using as substrate HIF1alpha CODDD,SCIENTIFIC LITERATURE,=,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/28928122,https://pubmed.ncbi.nlm.nih.gov/32880805,INHIBITOR,,Tclin,3050.0,3049.0,Homo sapiens
182166,657,2781,DNA gyrase,Enzyme,P0AES4|P0AES6,gyrA|gyrB,GYRA_ECOLI|GYRB_ECOLI,,,Mechanism of Action; CHEMBL2311224; PROTEIN COMPLEX,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1208,INHIBITOR,,,,,Escherichia coli (strain K12)
222006,5280,2170,Serine/threonine-protein kinase RIO1,Kinase,Q9BRS2,RIOK1,RIOK1_HUMAN,6.47,Kd,Binding constant for RIOK1 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
35088,928,816,Mitogen-activated protein kinase 3,Kinase,P27361,MAPK3,MK03_HUMAN,5.821,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
220954,3483,5537,7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase,Enzyme,Q9UNU6,CYP8B1,CP8B1_HUMAN,5.42,IC50,Inhibition of CYP8B1 in human liver microsomes using D7-7alpha-hydroxy-4-cholesten-3-one as substrate preincubated for 20 mins followed by substrate addition in presence of NADPH by UPLC-ESI-MS/MS analysis,CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
165745,1112,123,Canalicular multispecific organic anion transporter 1,Transporter,Q92887,ABCC2,MRP2_HUMAN,3.21,Km,,WOMBAT-PK,=,,,,,,,Tbio,,,Homo sapiens
165168,1802,2931,GABA A receptor alpha-5/beta-2/gamma-2,Ion channel,P18507|P31644|P47870,GABRG2|GABRA5|GABRB2,GBRG2_HUMAN|GBRA5_HUMAN|GBRB2_HUMAN,9.125,Ki,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL655,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
217662,294,1834,Glucocorticoid receptor,Transcription factor,P06536,Nr3c1,GCR_RAT,8.54,IC50,Steroid binding against the rat thymus glucocorticoid receptor,CHEMBL,=,,,,,,,,,,Rattus norvegicus
94126,575,58,Cannabinoid receptor 1,GPCR,P21554,CNR1,CNR1_HUMAN,4.07,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
34061,432,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,6.398,IC50,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
216276,903,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,6.1,Ki,,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
184823,995,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,9.05,Kd,GRAC: human 5-HT1D probe,CHEMBL,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1510,AGONIST,,Tclin,,,Homo sapiens
219135,1499,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.33,Ki,Displacement of [3H]spiperone from human D3 receptor expressed in CHO cells,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
218813,5347,2316,Mitogen-activated protein kinase kinase kinase kinase 2,Kinase,Q12851,MAP4K2,M4K2_HUMAN,5.68,Kd,Binding constant for MAP4K2 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
183425,1877,1740,Mu-type opioid receptor,GPCR,P33535,Oprm1,OPRM_RAT,8.7,Ki,Compound administered subcutaneously was evaluated for inhibition constant measured as the displacement of [3H]DAGO from rat brain,CHEMBL,=,,,,,,,,,,Rattus norvegicus
25928,1368,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,10.3,Ki,,IUPHAR,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
180692,1344,3412,Voltage-gated potassium channel,Ion channel,O43525|O43526|O95259|P16389|P17658|P22001|P22459|P22460|P48547|P51787|P56696|Q03721|Q09470|Q12809|Q14003|Q14721|Q16322|Q6PIU1|Q8NCM2|Q8TAE7|Q8TDN1|Q8TDN2|Q92953|Q96KK3|Q96L42|Q96PR1|Q96RP8|Q9BQ31|Q9H252|Q9H3M0|Q9NR82|Q9NS40|Q9NSA2|Q9NZV8|Q9UIX4|Q9UJ96|Q9UK17|Q9ULD8|Q9ULS6|Q9UQ05,KCNQ3|KCNQ2|KCNH1|KCNA2|KCNA6|KCNA3|KCNA4|KCNA5|KCNC1|KCNQ1|KCNQ4|KCNC4|KCNA1|KCNH2|KCNC3|KCNB1|KCNA10|KCNV1|KCNH5|KCNG3|KCNG4|KCNV2|KCNB2|KCNS1|KCNH8|KCNC2|KCNA7|KCNS3|KCNH6|KCNF1|KCNQ5|KCNH7|KCND1|KCND2|KCNG1|KCNG2|KCND3|KCNH3|KCNS2|KCNH4,KCNQ3_HUMAN|KCNQ2_HUMAN|KCNH1_HUMAN|KCNA2_HUMAN|KCNA6_HUMAN|KCNA3_HUMAN|KCNA4_HUMAN|KCNA5_HUMAN|KCNC1_HUMAN|KCNQ1_HUMAN|KCNQ4_HUMAN|KCNC4_HUMAN|KCNA1_HUMAN|KCNH2_HUMAN|KCNC3_HUMAN|KCNB1_HUMAN|KCA10_HUMAN|KCNV1_HUMAN|KCNH5_HUMAN|KCNG3_HUMAN|KCNG4_HUMAN|KCNV2_HUMAN|KCNB2_HUMAN|KCNS1_HUMAN|KCNH8_HUMAN|KCNC2_HUMAN|KCNA7_HUMAN|KCNS3_HUMAN|KCNH6_HUMAN|KCNF1_HUMAN|KCNQ5_HUMAN|KCNH7_HUMAN|KCND1_HUMAN|KCND2_HUMAN|KCNG1_HUMAN|KCNG2_HUMAN|KCND3_HUMAN|KCNH3_HUMAN|KCNS2_HUMAN|KCNH4_HUMAN,,,Mechanism of Action; CHEMBL2362996; PROTEIN FAMILY,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL821,BLOCKER,,Tclin|Tbio|Tchem|NA,,,Homo sapiens
188735,4728,1825,Arachidonate 5-lipoxygenase,Enzyme,P12527,Alox5,LOX5_RAT,5.05,IC50,In vitro inhibition of 5-lipoxygenase pathway in rat basophilic leukemia (RBL-1) cells,CHEMBL,=,,,,,,,,,,Rattus norvegicus
223277,2767,6272,Forkhead box protein M1,Unclassified,Q08050,FOXM1,FOXM1_HUMAN,7.28,Ki,Binding affinity to recombinant FOXM1 DBD (unknown origin) expressed in Escherichia coli BL21 (DE3) assessed as disruption of FOXM1-DNA complex preincubated for 1.5 hrs followed by DNA addition measured after 20 mins by EMSA,CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
134497,4855,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,,,Mechanism of Action,DRUG LABEL,,1.0,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21396_prempro_lbl.pdf,AGONIST,,Tclin,,535.0,Homo sapiens
222275,5280,2169,Protein-tyrosine kinase 2-beta,Kinase,Q14289,PTK2B,FAK2_HUMAN,7.54,Kd,Binding constant for PYK2 kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
27745,1592,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.337,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
26878,1764,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,8.3,Ki,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
36676,1893,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,4.615,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
34907,885,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,8.085,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
171390,820,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.2,IC50,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
217677,2422,2581,Protease,Enzyme,Q9YQ12,protease,Q9YQ12_9HIV1,10.4,Ki,Inhibition of wild-type HIV1 BH10 protease expressed in Escherichia coli by spectrophotometric assay,CHEMBL,=,,,,,,,,,,Human immunodeficiency virus 1
181541,2872,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,5.22,Ki,Inhibition of human recombinant CA5B by CO2 hydration assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
186823,785,865,Mitogen-activated protein kinase 14,Kinase,Q16539,MAPK14,MK14_HUMAN,7.57,Kd,Binding constant for full-length p38-alpha,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
187845,4190,2197,SRSF protein kinase 1,Kinase,Q96SB4,SRPK1,SRPK1_HUMAN,5.68,Kd,Binding constant for SRPK1 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
37941,2745,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.347,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
183087,2745,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,7.99,IC50,Evaluated for its binding affinity at human muscarinic receptor m5 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
185907,2073,1994,Trifunctional purine biosynthetic protein adenosine-3,Enzyme,P22102,GART,PUR2_HUMAN,6.42,Ki,Inhibition of GARFT,CHEMBL,=,1.0,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/021462lbl.pdf,INHIBITOR,,Tclin,,2308.0,Homo sapiens
223250,1282,6271,Transcription factor p65,Transcription factor,Q04206,RELA,TF65_HUMAN,7.26,IC50,Inhibition of NFkappaB p65 in human RPMI-8226 cells incubated for 2 hrs by ELISA,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
181266,2427,2594,3-oxoacyl-[acyl-carrier-protein] synthase 3,Enzyme,C3TDZ2,fabH,C3TDZ2_ECOLX,4.55,IC50,Inhibition of N-terminal His-tagged Escherichia coli FabH expressed in Escherichia coli BL21 (DE3) using [3H]acetyl-coA after 25 mins by liquid scintillation counting,CHEMBL,=,,,,,,,,,,Escherichia coli
221934,4654,870,Dual specificity protein kinase CLK1,Kinase,P49759,CLK1,CLK1_HUMAN,5.68,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
182562,3400,1940,Tissue factor,Membrane receptor,P13726,F3,TF_HUMAN,4.1,IC50,Inhibition of amidolytic activity of human tissue factor/human factor 7a,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
163864,2332,2308,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,Q27793,,DRTS_TRYCR,7.009,Ki,,WOMBAT-PK,=,,,,,,,,,,Trypanosoma cruzi
217190,2637,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,7.2,Ki,,IUPHAR,=,,,,,ANTAGONIST,,,,,Rattus norvegicus
218192,5309,1935,Plasma kallikrein,Enzyme,P03952,KLKB1,KLKB1_HUMAN,10.05,IC50,,IUPHAR,=,1.0,DRUG LABEL,https://pubmed.ncbi.nlm.nih.gov/30267321,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761090s000lbl.pdf,ANTIBODY BINDING,,Tclin,2548.0,2549.0,Homo sapiens
220904,74,5480,Nicotinate phosphoribosyltransferase,Enzyme,Q6XQN6,NAPRT,PNCB_HUMAN,9.3,Ki,Inhibition of NAPRT (unknown origin),CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
164631,2113,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.088,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
37557,2495,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,5.431,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
183976,397,72,Thymidine kinase,Kinase,Q9QNF7,TK,KITH_HHV1,6.62,Ki,Inhibition of Herpes simplex virus 1 recombinant thymidine kinase,CHEMBL,=,,,,,,,,,,Human herpesvirus 1
35927,1457,816,Mitogen-activated protein kinase 3,Kinase,P27361,MAPK3,MK03_HUMAN,5.279,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
26720,1805,151,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,O75469,NR1I2,NR1I2_HUMAN,5.0,EC50,,IUPHAR,~,,,,,AGONIST,,Tchem,,,Homo sapiens
185705,2389,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,7.66,Ki,Displacement of [3H]mepyramine from histamine H1 receptor in guinea pig cerebellum after 60 mins by liquid scintillation counting analysis,CHEMBL,=,,,,,,,,,,Cavia porcellus
188943,4903,2317,Misshapen-like kinase 1,Kinase,Q8N4C8,MINK1,MINK1_HUMAN,7.09,Kd,Binding constant for MINK kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
215678,228,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,5.91,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
37680,2561,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,5.407,Ki,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
220922,5288,1976,Fatty-acid amide hydrolase 1,Enzyme,P97612,Faah,FAAH1_RAT,4.27,IC50,Inhibition of FAAH in rat brain membranes using [14C]-AEA as substrate measured after 30 mins by scintillation counting method,CHEMBL,=,,,,,,,,,,Rattus norvegicus
163022,812,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.755,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
162469,864,330,Carbonic anhydrase 12,Enzyme,O43570,CA12,CAH12_HUMAN,7.301,Ki,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17,INHIBITOR,,Tclin,,,Homo sapiens
181524,2233,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,9.35,Ki,Displacement of [3H]R(+)-7-OH-DPAT from Sprague-Dawley rat dopamine D3 receptor after 90 mins,CHEMBL,=,,,,,,,,,,Rattus norvegicus
216402,3952,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.68,IC50,,CHEMBL,=,,,,,,,,,,Rattus norvegicus
181909,2121,1881,Cholinesterase,Enzyme,Q03311,Bche,CHLE_MOUSE,6.28,Ki,Compound was evaluated for the protection of butyrylcholinesterase against DFT in mice,CHEMBL,=,,,,,,,,,,Mus musculus
33961,333,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.654,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
220901,2237,667,Bile acid receptor,Nuclear hormone receptor,Q96RI1,NR1H4,NR1H4_HUMAN,4.82,EC50,Partial agonist activity at human full-length FXR expressed in human HeLa cells co-expressing pSG5-RXR measured after 24 hrs by dual-glo luciferase reporter gene assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
26871,2601,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,8.5,Ki,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
188091,4225,892,Cyclin-dependent kinase 16,Kinase,Q00536,CDK16,CDK16_HUMAN,5.28,Kd,Binding constant for PCTK1 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
223192,880,6279,2-amino-3-carboxymuconate-6-semialdehyde decarboxylase,Unclassified,Q8TDX5,ACMSD,ACMSD_HUMAN,5.59,Ki,Competitive inhibition of human ACMSD using ACMS substrate by spectrometry,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
165301,4501,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
218860,5347,2238,Mitogen-activated protein kinase kinase kinase 9,Kinase,P80192,MAP3K9,M3K9_HUMAN,5.5,Kd,Binding constant for MLK1 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
186606,3178,3481,Protein-tyrosine phosphatase 1C,Enzyme,P29350,PTPN6,PTN6_HUMAN,4.18,IC50,Inhibition of recombinant SHP1,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
180958,52,319,Carbonic anhydrase 9,Enzyme,Q16790,CA9,CAH9_HUMAN,4.15,Ki,Inhibition of human carbonic anhydrase 9 catalytic domain by stopped-flow CO2 hydration assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
223026,1751,5990,Bifunctional purine biosynthesis protein PURH,Enzyme,P31939,ATIC,PUR9_HUMAN,6.06,Ki,Inhibition of human full length N-terminal His-tagged ATIC expressed in Chinese Hamster MTXRII-OuaR2-4 R2 cells assessed as reduction in THF formation using 10-CHOTHF as substrate by spectrophotometric method,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
185072,203,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.68,IC50,Inhibition of human ERG potassium channel,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
164271,1751,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
187802,4187,2084,Cyclin-dependent kinase 7,Kinase,P50613,CDK7,CDK7_HUMAN,6.48,Kd,Binding constant for CDK7 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
189190,2697,632,Catechol O-methyltransferase,Enzyme,P21964,COMT,COMT_HUMAN,9.569,Ki,,SCIENTIFIC LITERATURE,=,1.0,CHEMBL,https://pubmed.ncbi.nlm.nih.gov/7703232,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1324,INHIBITOR,1.0,Tclin,389.0,,Homo sapiens
36993,2142,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.347,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
216705,2337,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,7.06,IC50,,CHEMBL,=,,,,,,,,,,Rattus norvegicus
222199,5280,2181,Casein kinase II subunit alpha',Kinase,P19784,CSNK2A2,CSK22_HUMAN,7.85,Kd,Binding constant for CSNK2A2 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
188557,4512,3494,Inositol-1(or 4)-monophosphatase 1,Enzyme,P29218,IMPA1,IMPA1_HUMAN,,,Mechanism of Action; CHEMBL1786; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201170,INHIBITOR,,Tclin,,,Homo sapiens
220412,113,5123,Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1,Enzyme,Q8WUK0,PTPMT1,PTPM1_HUMAN,7.97,IC50,Activity measured in the presence of substrate O-MFP in an in vitro assay,SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/20167843,,INHIBITOR,,Tbio,3190.0,,Homo sapiens
221835,5280,2227,Serine/threonine-protein kinase MARK1,Kinase,Q9P0L2,MARK1,MARK1_HUMAN,6.57,Kd,Binding constant for MARK1 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
192302,2800,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,8.56,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
181066,1920,2727,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,P09483|P12390,Chrna4|Chrnb2,ACHA4_RAT|ACHB2_RAT,9.4,Kd,GRAC: rat AChR-alpha4-beta2 radioligand,CHEMBL,=,,,,,,,,,,Rattus norvegicus
183475,1202,2759,GABA-A receptor; anion channel,Ion channel,O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,Gabrp|Gabrb1|Gabrd|Gabrg2|Gabra5|Gabra3|Gabrg1|Gabra2|Gabra4|Gabrg3|Gabra6|Gabra1|Gabrb3|Gabrb2|Gabrq|Gabre,GBRP_RAT|GBRB1_RAT|GBRD_RAT|GBRG2_RAT|GBRA5_RAT|GBRA3_RAT|GBRG1_RAT|GBRA2_RAT|GBRA4_RAT|GBRG3_RAT|GBRA6_RAT|GBRA1_RAT|GBRB3_RAT|GBRB2_RAT|Q91ZM7_RAT|GBRE_RAT,8.82,IC50,Displacement of [3H]diazepam from GABA-A Benzodiazepine receptor of rat forebrain,CHEMBL,=,,,,,,,,,,Rattus norvegicus
221784,4810,748,LIM domain kinase 1,Kinase,P53667,LIMK1,LIMK1_HUMAN,4.68,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
222946,1517,525,Apoptosis regulator Bcl-2,Cytosolic other,P10415,BCL2,BCL2_HUMAN,6.47,Kd,Binding affinity to human recombinant Bcl-2 expressed in Escherichia coli by Surface plasmon resonance assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
186933,1365,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,,,Mechanism of Action; CHEMBL220; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201349,INHIBITOR,,Tclin,,,Homo sapiens
181374,2551,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,8.61,IC50,Inhibition of equine BuChE using butyrylthiocholine iodide as substrate preincubated for 5 mins before substrate addition measured for 10 mins by Ellman's method,CHEMBL,=,,,,,,,,,,Equus caballus
222228,4946,5957,Beta-lactamase,Enzyme,A8DS27,blaKPC-2,A8DS27_ECOLX,7.96,Ki,Inhibition of recombinant Escherichia coli KPC-2 using nitrocefin as substrate preincubated for 10 mins followed by substrate addition and measured every 10 secs for 10 mins by spectrophotometric analysis,CHEMBL,=,,,,,,,,,,Escherichia coli
222975,564,5390,Alpha-synuclein,Transporter,P37840,SNCA,SYUA_HUMAN,6.28,Kd,Binding affinity to alpha-synuclein (unknown origin) expressed in Escherichia coli BL21(DE3) by circular dichroism analysis,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
221138,1574,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,5.1,IC50,Inhibition of human OCT1 expressed in HEK293 cells assessed as reduction in ASP+ substrate uptake by microplate reader based analysis,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
26521,99,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,5.4,Ki,,IUPHAR,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
184896,437,1858,Alpha-1A adrenergic receptor,GPCR,P18130,ADRA1A,ADA1A_BOVIN,4.8,IC50,Binding affinity against alpha-1 adrenergic receptor in calf frontal cortex,CHEMBL,=,,,,,,,,,,Bos taurus
187900,4190,2214,Serine/threonine-protein kinase PAK 6,Kinase,Q9NQU5,PAK6,PAK6_HUMAN,5.54,Kd,Binding constant for PAK6 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
36126,1599,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,5.599,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
216769,1531,3872,CAAX prenyl protease 2,Enzyme,Q03530,RCE1,RCE1_YEAST,4.82,AC50,Active,CHEMBL,=,,,,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
185295,2544,2137,Non-receptor tyrosine-protein kinase TYK2,Kinase,P29597,TYK2,TYK2_HUMAN,6.44,Kd,Binding affinity to TYK2(JH2domain-pseudokinase),CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
184679,1280,165,DNA gyrase subunit A,Enzyme,P9WG47,gyrA,GYRA_MYCTU,5.03,IC50,Inhibition of DNA supercoiling activity of wild type Mycobacterium tuberculosis DNA gyrase A,CHEMBL,=,,,,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
217204,2815,4073,Two pore calcium channel protein 2,Ion channel,Q8NHX9,TPCN2,TPC2_HUMAN,5.0,IC50,,IUPHAR,=,,,,,BLOCKER,,,,,Homo sapiens
185418,726,2869,Tubulin,Structural,P02550|P02554,TUBA1A,TBA1A_PIG|TBB_PIG,5.24,Ki,Binding affinity against tubulin usingf [3H]-colchicine as radioligand,CHEMBL,=,,,,,,,,,,Sus scrofa
218817,5347,883,Cyclin-G-associated kinase,Kinase,O14976,GAK,GAK_HUMAN,8.96,Kd,Binding constant for GAK kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
221006,1797,642,Potassium channel subfamily K member 9,Ion channel,Q9NPC2,KCNK9,KCNK9_HUMAN,4.61,IC50,Inhibition of human TASK3 expressed in HEK293 cells by Ti+ flux assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
215944,215,3834,Testosterone 17-beta-dehydrogenase 3,Enzyme,O54939,Hsd17b3,DHB3_RAT,6.77,IC50,,CHEMBL,=,,,,,,,,,,Rattus norvegicus
163067,1830,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.157,IC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL460,ANTAGONIST,,Tclin,,,Homo sapiens
216786,5039,2436,Carbonic anhydrase,Enzyme,Q2PCB5,ca,Q2PCB5_DICLA,5.03,Ki,,CHEMBL,=,,,,,,,,,,Dicentrarchus labrax
220250,5426,679,Tyrosine-protein kinase JAK1,Kinase,P23458,JAK1,JAK1_HUMAN,8.55,IC50,ATP concentration at the Km specific for JAK1 of 40 Î¼M,SCIENTIFIC LITERATURE,=,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/25387665,https://pubmed.ncbi.nlm.nih.gov/25387665,INHIBITOR,,Tclin,3057.0,3057.0,Homo sapiens
34260,654,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,6.333,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
35972,1527,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,5.665,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
181979,2332,2610,Multidrug and toxin extrusion protein 1,Unclassified,Q8K0H1,Slc47a1,S47A1_MOUSE,6.84,Ki,Inhibition of mouse Mate1 transfected in HEK293 cells assessed as uptake of [14C]-TEA preincubated for 15 mins by liquid scintillation counting analysis,CHEMBL,=,,,,,,,,,,Mus musculus
162818,260,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,9.29,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
182011,754,436,Dihydrofolate reductase,Enzyme,P16184,,DYR_PNECA,7.63,Ki,Binding affinity was reported with purified recombinant Pneumocystis carinii Dihydrofolate reductase,CHEMBL,=,,,,,,,,,,Pneumocystis carinii
222179,4937,6019,Peroxisomal acyl-coenzyme A oxidase 1,Enzyme,Q15067,ACOX1,ACOX1_HUMAN,6.57,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
35824,1355,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.339,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
216778,5201,696,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",Enzyme,Q13946,PDE7A,PDE7A_HUMAN,6.14,IC50,,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
217652,1211,1801,D(1A) dopamine receptor,GPCR,Q95136,DRD1,DRD1_BOVIN,7.75,Ki,Binding affinity of compound towards Dopamine receptor D1 using [3H]SCH-23390 (0.5 nM) ligand in striatum bovine was determined,CHEMBL,=,,,,,,,,,,Bos taurus
186892,1423,682,Carbonic anhydrase 3,Enzyme,P07451,CA3,CAH3_HUMAN,6.28,Ki,Inhibition of human carbonic anhydrase 3 by stopped flow CO2 hydration assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
164313,2298,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
187873,4190,871,Dual specificity protein kinase CLK2,Kinase,P49760,CLK2,CLK2_HUMAN,6.34,Kd,Binding constant for CLK2 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
217209,2824,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.2,Kd,,IUPHAR,=,,,,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
34188,621,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.724,Ki,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
142193,2678,2538,Muscarinic acetylcholine receptor,GPCR,F1PWR7,CHRM2,F1PWR7_CANFA,8.94,Ki,radioligand ([3H]QNB) displacement assay,SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/8839659,,,,,61.0,,Canis familiaris
38058,3018,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,5.649,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
189223,5022,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.31,Ki,,SCIENTIFIC LITERATURE,=,1.0,DRUG LABEL,https://pubmed.ncbi.nlm.nih.gov/12177684,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022526lbl.pdf,ANTAGONIST,,Tclin,416.0,417.0,Homo sapiens
188465,4359,2231,Tyrosine-protein kinase Mer,Kinase,Q12866,MERTK,MERTK_HUMAN,6.96,Kd,Binding constant for MERTK kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
181409,3591,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1b|Adra1d|Adra1a,ADA1B_RAT|ADA1D_RAT|ADA1A_RAT,5.8,IC50,Binding affinity against alpha-1 adrenergic receptor is the ability to inhibit the specific [3H]prazosin binding (0.2 nM) to rat isolated brain membranes by 50% was reported; 1.6*10e-6,CHEMBL,=,,,,,,,,,,Rattus norvegicus
188227,4318,868,Tyrosine-protein kinase FRK,Kinase,P42685,FRK,FRK_HUMAN,5.85,Kd,Binding constant for FRK kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
216946,6,150,Intermediate conductance calcium-activated potassium channel protein 4,Ion channel,O15554,KCNN4,KCNN4_HUMAN,7.6,IC50,,IUPHAR,=,,,,,BLOCKER,,Tchem,,,Homo sapiens
217962,5231,1253,Inhibitor of nuclear factor kappa-B kinase subunit beta,Kinase,O14920,IKBKB,IKKB_HUMAN,5.2,Kd,Binding constant for IKK-beta kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
220592,629,383,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,4.8,IC50,Inhibition of N-terminal GST-His-tagged c-KIT (544 to 976 amino acids) D816V mutant (unknown origin) expressed in Sf9 insect cells using poly[Glu:Tyr] (4:1) as substrate preincubated for 20 mins followed by [33P-gamma]ATP addition and subsequent inhibition for 2 hrs by radiometric assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
95758,1795,347,Aldo-keto reductase family 1 member C3,Enzyme,P42330,AKR1C3,AK1C3_HUMAN,6.12,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
182451,180,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.77,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
185878,945,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.46,Ki,Displacement of [125I]iodosulpiride from human Dopamine receptor D3 expressed in CHO cells,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
219155,4267,2031,Polyphenol oxidase 2,Enzyme,O42713,PPO2,PPO2_AGABI,4.0,IC50,Inhibition of mushroom tyrosinase using L-tyrosine as a substrate after 30 mins by spectrophotometric method,CHEMBL,=,,,,,,,,,,Agaricus bisporus
220660,1920,3917,Transient receptor potential cation channel subfamily A member 1,Ion channel,Q8BLA8,Trpa1,TRPA1_MOUSE,5.0,EC50,Agonist activity at mouse TRPA1 expressed in CHO cells assessed as increase in calcium influx by patch clamp electrophysiology method,CHEMBL,=,,,,,,,,,,Mus musculus
223576,3514,1047,Cystic fibrosis transmembrane conductance regulator,Ion channel,P13569,CFTR,CFTR_HUMAN,4.59,Kd,Binding affinity to sensorchip-immobilized human His-tagged CFTR F508 deletion mutant by surface plasmon resonance analysis,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
216674,1001,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,5.19,IC50,,CHEMBL,=,,,,,,,,,,Rattus norvegicus
187309,3483,2421,14-alpha sterol demethylase Cyp51A,Enzyme,Q4WNT5,,Q4WNT5_ASPFU,5.57,Kd,Binding affinity to Aspergillus fumigatus AF293 sterol 14-alpha demethylase isoenzyme A expressed in Escherichia coli,CHEMBL,=,,,,,,,,,,Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100)
37909,2717,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,6.75,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
188581,4608,1932,Tyrosine-protein phosphatase 1,Enzyme,P25044,PTP1,PTP1_YEAST,5.13,IC50,Inhibitory activity against Saccharomyces cerevisiae Tyrosine phosphatase 1,CHEMBL,=,,,,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
220281,5410,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,7.3,IC50,Activity measured in LNCaP cells,DRUG LABEL,=,,,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/213433Orig1s000MultidisciplineR.pdf,,ANTAGONIST,1.0,Tclin,3080.0,,Homo sapiens
185757,3481,2869,Tubulin,Structural,P02550|P02554,TUBA1A,TBA1A_PIG|TBB_PIG,5.66,Ki,Binding affinity against tubulin using [3H]colchicine as radioligand,CHEMBL,=,,,,,,,,,,Sus scrofa
181489,2558,2850,Adrenergic receptor alpha-2,GPCR,P19328|P22086|P22909,Adra2b|Adra2c|Adra2a,ADA2B_RAT|ADA2C_RAT|ADA2A_RAT,7.6,IC50,Binding affinity against Alpha-2 adrenergic receptor is the ability to inhibit the specific [3H]clonidine binding (0.4 nM) to rat isolated brain membranes by 50% was reported; 2.5*10e-8,CHEMBL,=,,,,,,,,,,Rattus norvegicus
223541,1992,2389,5-hydroxytryptamine receptor 3A,Ion channel,O70212,HTR3A,5HT3A_CAVPO,7.11,Kd,Antagonist activity at 5-HT3 receptor in guinea-pig ileum assessed as inhibition of 5HT-induced contraction incubated for 15 mins,CHEMBL,=,,,,,,,,,,Cavia porcellus
163000,1342,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL765,SUBSTRATE,,Tclin,,,Homo sapiens
183244,1071,814,Glutathione S-transferase A1,Enzyme,P08263,GSTA1,GSTA1_HUMAN,5.3,IC50,Inhibition of GST A1-1,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
223382,5678,3648,Granulocyte colony-stimulating factor receptor,Membrane receptor,Q99062,CSF3R,CSF3R_HUMAN,8.44,Kd,,DRUG LABEL,=,1.0,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/761148Orig1s000PharmR.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761148Orig1s000Corrected_lbl.pdf,AGONIST,,Tclin,3530.0,3529.0,Homo sapiens
33709,176,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,5.039,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
180698,58,2747,Bacterial urease,Enzyme,Q03282|Q03283|Q03284,ureA|ureB|ureC,URE3_ECOLX|URE2_ECOLX|URE1_ECOLX,,,Mechanism of Action; CHEMBL2364683; PROTEIN COMPLEX,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL734,INHIBITOR,,,,,Escherichia coli
218617,1314,4502,Sur1-Trpm4; Sulfonylurea receptor 1 - Transient receptor potential melastatin 4,Ion channel,Q09429|Q9ESQ5,Abcc8|Trpm4,ABCC8_RAT|TRPM4_RAT,7.32,EC50,activity measured in native reactive (type R1) rat astrocytes,SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/13679426,,INHIBITOR,,Tclin|Tclin,2885.0,,Rattus norvegicus
213504,5039,690,Carbonic anhydrase 6,Enzyme,P23280,CA6,CAH6_HUMAN,4.75,Ki,Inhibition of human CA6 using 4-nitrophenylacetate substrate by esterase assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
182773,2755,241,Dihydrofolate reductase,Enzyme,P00374,DHFR,DYR_HUMAN,8.0,Ki,Inhibition of recombinant Dihydrofolate reductase from humans.,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
224174,1427,843,Voltage-dependent N-type calcium channel subunit alpha-1B,Ion channel,Q00975,CACNA1B,CAC1B_HUMAN,4.66,IC50,Inhibition of endogenous human CaV2.2 in human SH-SY5Y cells in presence of nifedipine by Calcium 4 dye based calcium influx fluorescence-imaging assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
164253,1882,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,6.7,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
183550,3557,1768,Delta-type opioid receptor,GPCR,P33533,Oprd1,OPRD_RAT,4.54,IC50,In vitro inhibition of [3H]- [p-Cl-Phe4]DPDPE binding to Opioid receptor delta 1 using rat brain membranes.,CHEMBL,=,,,,,,,,,,Rattus norvegicus
216765,1067,2119,Lanosterol 14-alpha demethylase,Enzyme,P9WPP9,cyp51,CP51_MYCTU,4.0,Kd,,CHEMBL,=,,,,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
216761,960,3902,UDP-galactopyranose mutase,Enzyme,P9WIQ1,glf,GLF_MYCTU,4.49,AC50,active,CHEMBL,=,,,,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
181708,1863,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,,,Mechanism of Action; CHEMBL230; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1070,INHIBITOR,,Tclin,,,Homo sapiens
187755,4187,823,Ephrin type-A receptor 6,Kinase,Q9UF33,EPHA6,EPHA6_HUMAN,7.19,Kd,Binding constant for EPHA6 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
216780,849,3869,Female germline-specific tumor suppressor gld-1,Unclassified,Q17339,gld-1,GLD1_CAEEL,5.14,IC50,Active,CHEMBL,=,,,,,,,,,,Caenorhabditis elegans
134553,1987,2849,Phosphodiesterase 3,Enzyme,Q13370|Q14432,PDE3B|PDE3A,PDE3B_HUMAN|PDE3A_HUMAN,,,Mechanism of Action,DRUG LABEL,,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/9726653,INHIBITOR,,Tclin|Tclin|Tclin|Tclin,,288.0,Homo sapiens
187745,4187,2204,Ankyrin repeat and protein kinase domain-containing protein 1,Kinase,Q8NFD2,ANKK1,ANKK1_HUMAN,6.11,Kd,Binding constant for ANKK1 kinase domain,CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
186184,1282,2245,Citron Rho-interacting kinase,Kinase,O14578,CIT,CTRO_HUMAN,5.89,Kd,Binding constant for CIT kinase domain,CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
215404,495,390,Vasopressin V1a receptor,GPCR,P37288,AVPR1A,V1AR_HUMAN,7.39,EC50,,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
172480,4934,3405,Interleukin-17A,Cytokine,Q16552,IL17A,IL17_HUMAN,,,Mechanism of Action,SCIENTIFIC LITERATURE,,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/23253932,https://pubmed.ncbi.nlm.nih.gov/23253932,ANTIBODY BINDING,1.0,Tclin,153.0,153.0,Homo sapiens
185710,2389,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.55,Ki,Binding affinity to human cloned muscarinic M1 receptor,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
164230,958,209,Thymidylate synthase,Enzyme,P04818,TYMS,TYSY_HUMAN,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
214692,1310,1127,Excitatory amino acid transporter 2,Transporter,P43004,SLC1A2,EAA2_HUMAN,4.21,Ki,Inhibition of [3H]D-Asp uptake at human EAAT2 in HEK293 cells,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
219392,391,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,5.17,Ki,Inhibition of human CA5B by stopped-flow CO2 hydrase assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
215967,4305,2549,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,O77746,PDE5A,PDE5A_CANFA,8.28,IC50,,CHEMBL,=,,,,,,,,,,Canis familiaris
186253,1751,2102,Dihydrofolate reductase,Enzyme,B0BL08,dfrA17,B0BL08_ECOLX,10.68,Ki,Binding affinity against Dihydrofolate reductase of Escherichia coli,CHEMBL,=,,,,,,,,,,Escherichia coli
163388,1027,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
223234,5537,1768,Delta-type opioid receptor,GPCR,P33533,Oprd1,OPRD_RAT,9.57,Ki,Binding affinity against Opioid receptor delta 1 isolated from rat brain membrane was determined using [3H][Ile]-deltorphin as radioligand,CHEMBL,=,,,,,,,,,,Rattus norvegicus
37865,2651,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.108,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
187826,4187,2454,Mitogen-activated protein kinase kinase kinase 12,Kinase,Q12852,MAP3K12,M3K12_HUMAN,6.77,Kd,Binding constant for DLK kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
181560,3201,2104,Glutamate receptor 1,Ion channel,P19490,Gria1,GRIA1_RAT,6.32,Ki,"Displacement of (R,S)-[5-methyl-3H]AMPA from rat recombinant flop iGluR1 expressed in Sf9 cells",CHEMBL,=,,,,,,,,,,Rattus norvegicus
188469,4362,1912,Catechol O-methyltransferase,Enzyme,P22734,Comt,COMT_RAT,5.15,IC50,Inhibition of Sprague-Dawley rat liver COMT after 10 mins using 0.05 uCi [14CH3]-SAM as substrate,CHEMBL,=,,,,,,,,,,Rattus norvegicus
186642,2441,770,"Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'",Enzyme,P51160,PDE6C,PDE6C_HUMAN,7.41,IC50,Inhibition of human recombinant PDE6C at 1 uM by [3H]cGMP based tritium scintillation proximity assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
188422,4359,2132,Serine/threonine-protein kinase DCLK3,Kinase,Q9C098,DCLK3,DCLK3_HUMAN,5.27,Kd,Binding constant for DCAMKL3 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
184919,3584,1734,Alpha-1D adrenergic receptor,GPCR,P23944,Adra1d,ADA1D_RAT,9.0,Ki,In vitro binding affinity using [3H]prazosin as radioligand against adrenoceptor alpha 1d expressed in LTK cell,CHEMBL,=,,,,,,,,,,Rattus norvegicus
223243,5571,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.61,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
163281,786,192,Multidrug resistance-associated protein 6,Transporter,O95255,ABCC6,MRP6_HUMAN,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
186241,537,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,mrcA|mrcB|dacC|mrdA|ftsI|dacA|dacB,PBPA_ECOLI|PBPB_ECOLI|DACC_ECOLI|PBP2_ECOLI|FTSI_ECOLI|DACA_ECOLI|DACB_ECOLI,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1541,INHIBITOR,,,,,Escherichia coli (strain K12)
184083,2706,2006,Carbonic anhydrase 2,Enzyme,P27139,Ca2,CAH2_RAT,5.85,IC50,Inhibition concentration against carbonic anhydrase II in rat determined in esterase assay,CHEMBL,=,,,,,,,,,,Rattus norvegicus
3197,720,119,Penicillin-binding protein 1A,Enzyme,Q8XJ01,pbpA,PBPA_CLOPE,,,,WOMBAT-PK,,,,,,,,,,,Clostridium perfringens (strain 13 / Type A)
215467,647,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,6.49,EC50,,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
27489,2276,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,7.602,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
219561,607,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.48,Ki,Activity of compound against Muscarinic acetylcholine receptor M3 (CHRM3) by displacement of 3H-QNB,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
216358,2422,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.37,IC50,,CHEMBL,=,,,,,,,,,,Rattus norvegicus
184572,1783,185,Solute carrier family 12 member 3,Transporter,P55017,SLC12A3,S12A3_HUMAN,,,Mechanism of Action; CHEMBL1876; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL878,INHIBITOR,,Tclin,,,Homo sapiens
25628,460,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,9.2,Ki,,IUPHAR,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201087,AGONIST,,Tclin,,,Homo sapiens
36558,1820,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.1,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
220487,1358,4394,Spike glycoprotein,Glycoprotein,P0DTC2,S,SPIKE_SARS2,10.14,Kd,Binding affinity of trimeric SARS-CoV-2 spike protein to immobilized heparin.,IUPHAR,=,,,,,,,,,,Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
35138,945,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,5.781,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
220608,1805,5251,Glucocorticoid receptor,Nuclear hormone receptor,F1Q298,NR3C1,F1Q298_CANLF,7.7,IC50,Antagonist activity at GR in dog PBMC assessed as reduction in dexamethasone-induced FKBP5 gene expression incubated for 6 hrs by RT-qPCR method,CHEMBL,=,,,,,,,,,,Canis lupus familiaris
164007,873,353,Arachidonate 5-lipoxygenase,Enzyme,P09917,ALOX5,LOX5_HUMAN,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
162880,581,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,7.91,Ki,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1000,ANTAGONIST,,Tclin,,,Homo sapiens
184417,3275,376,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,6.65,Ki,compound was tested for inhibitory activity against Thrombin,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
34088,444,251,Acetylcholinesterase,Enzyme,P22303,ACHE,ACES_HUMAN,5.161,IC50,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
222777,369,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,5.38,Ki,Inhibition of monoamine oxidase (MAO) in human brain synaptosomes,IUPHAR,=,,,,,INHIBITOR,,Tclin,,,Homo sapiens
224165,1728,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,4.58,Ki,Displacement of [3H]-N-methylspiperone from human dopamine D4 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
218363,4468,2779,Glutamate NMDA receptor,Ion channel,P35439|Q00959|Q00960|Q00961|Q62645|Q8VHN2|Q9R1M7,Grin1|Grin2a|Grin2b|Grin2c|Grin2d|Grin3b|Grin3a,NMDZ1_RAT|NMDE1_RAT|NMDE2_RAT|NMDE3_RAT|NMDE4_RAT|NMD3B_RAT|NMD3A_RAT,6.161,Ki,,SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/23183107,,ANTAGONIST,,,2702.0,,Rattus norvegicus
218830,5347,908,Calcium/calmodulin-dependent protein kinase kinase 2,Kinase,Q96RR4,CAMKK2,KKCC2_HUMAN,5.4,Kd,Binding constant for CAMKK2 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
222395,5280,721,Calcium/calmodulin-dependent protein kinase type II subunit delta,Kinase,Q13557,CAMK2D,KCC2D_HUMAN,5.52,Kd,Binding constant for CAMK2D kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
184987,1045,2222,Tyrosine-protein kinase Blk,Kinase,P51451,BLK,BLK_HUMAN,6.72,Kd,Binding constant for BLK kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
164479,2245,128,Annexin A1,Cytosolic other,P04083,ANXA1,ANXA1_HUMAN,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
182664,3424,2842,Opioid receptor,GPCR,P33533|P33535|P34975|Q9R0C9,Oprd1|Oprm1|Oprk1|Sigmar1,OPRD_RAT|OPRM_RAT|OPRK_RAT|SGMR1_RAT,7.9,IC50,Inhibition of [3H]-Naloxone binding to rat brain membrane without NaCl,CHEMBL,=,,,,,,,,,,Rattus norvegicus
36660,1893,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,4.909,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
28020,663,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.875,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
215402,5110,495,"Maltase-glucoamylase, intestinal",Enzyme,O43451,MGAM,MGA_HUMAN,5.82,IC50,,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
222567,5280,2264,Ephrin type-A receptor 1,Kinase,P21709,EPHA1,EPHA1_HUMAN,7.17,Kd,Binding constant for EPHA1 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
26451,3652,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,5.9,Ki,,IUPHAR,=,,,,,AGONIST,,Tchem,,,Homo sapiens
163213,937,55,Beta-2 adrenergic receptor,GPCR,P07550,ADRB2,ADRB2_HUMAN,6.2,EC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL926,AGONIST,,Tclin,,,Homo sapiens
224190,4072,3413,Urease,Enzyme,P07374,,UREA_CANEN,5.07,IC50,Inhibition of jack bean urease,CHEMBL,=,,,,,,,,,,Canavalia ensiformis
185860,565,3447,Bacterial penicillin-binding protein,Enzyme,P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,mrcA|mrcB|dacC|mrdA|ftsI|dacA|dacB,PBPA_ECOLI|PBPB_ECOLI|DACC_ECOLI|PBP2_ECOLI|FTSI_ECOLI|DACA_ECOLI|DACB_ECOLI,,,Mechanism of Action; CHEMBL2354204; PROTEIN FAMILY,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2146124,INHIBITOR,,,,,Escherichia coli (strain K12)
222189,2846,5959,14-alpha sterol demethylase,Enzyme,G4WW85,cyp51A,G4WW85_ASPNG,7.25,Kd,Binding affinity to Aspergillus fumigatus CYP51 by spectral titration method,CHEMBL,=,,,,,,,,,,Aspergillus niger
27668,1752,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,9.237,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
222085,5280,2211,Serine/threonine-protein kinase LATS2,Kinase,Q9NRM7,LATS2,LATS2_HUMAN,5.4,Kd,Binding constant for LATS2 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
218390,5345,894,Activated CDC42 kinase 1,Kinase,Q07912,TNK2,ACK1_HUMAN,7.15,IC50,,SCIENTIFIC LITERATURE,=,,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/212725s000lbl.pdf,,INHIBITOR,,Tclin,2709.0,,Homo sapiens
218956,704,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,6.22,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
189285,5052,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,9.097,Ki,,DRUG LABEL,=,,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207533s000lbl.pdf,,,,Tclin,454.0,,Homo sapiens
220731,792,5507,Deoxyhypusine hydroxylase,Enzyme,Q9BU89,DOHH,DOHH_HUMAN,5.3,IC50,Inhibition of DOHH (unknown origin),CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
181671,56,1753,Carbonic anhydrase 4,Enzyme,Q95323,CA4,CAH4_BOVIN,7.15,Ki,Compound was evaluated for inhibition against bovine carbonic anhydrase IV,CHEMBL,=,,,,,,,,,,Bos taurus
37426,2405,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.391,IC50,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
221273,2266,2586,Reverse transcriptase,Enzyme,Q9WKE8,reverse transcriptas,Q9WKE8_9HIV1,4.0,IC50,Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins by scintillation counting method,CHEMBL,=,,,,,,,,,,Human immunodeficiency virus 1
180964,2149,1734,Alpha-1D adrenergic receptor,GPCR,P23944,Adra1d,ADA1D_RAT,5.07,Ki,Binding affinity to Rattus norvegicus (rat) alpha1D adrenoreceptor by radioligand displacement assay,CHEMBL,=,,,,,,,,,,Rattus norvegicus
215660,1150,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.172,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
221894,5306,665,Mitogen-activated protein kinase 8,Kinase,P45983,MAPK8,MK08_HUMAN,6.13,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
164050,788,313,Amine oxidase [flavin-containing] A,Enzyme,P21397,MAOA,AOFA_HUMAN,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
95667,1744,2515,NH(3)-dependent NAD(+) synthetase,Enzyme,P18843,nadE,NADE_ECOLI,5.5,IC50,,WOMBAT-PK,=,,,,,,,,,,Escherichia coli (strain K12)
162595,1087,204,Voltage-dependent T-type calcium channel subunit alpha-1G,Ion channel,O43497,CACNA1G,CAC1G_HUMAN,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL696,BLOCKER,,Tclin,,,Homo sapiens
184394,3659,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,7.02,IC50,Inhibitory concentration against human Adenosine A3 receptor expressed in HEK293 cells using 0.1 nM [3H]AB-MECA,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
222579,4715,797,Abelson tyrosine-protein kinase 2,Kinase,P42684,ABL2,ABL2_HUMAN,6.04,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
216891,484,3875,Beta-lactamase class B VIM-2,Unclassified,Q9K2N0,blaVIM-2,Q9K2N0_PSEAI,6.22,Kd,,CHEMBL,=,,,,,,,,,,Pseudomonas aeruginosa
164824,2337,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.83,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
183327,44,3555,"Dihydropteroate synthetase, putative",Unclassified,Q4Z710,,Q4Z710_PLABA,4.75,IC50,Inhibitory activity against dihydropteroic acid synthase (SYN) from Plasmodium berghei,CHEMBL,=,,,,,,,,,,Plasmodium berghei (strain Anka)
217648,837,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,6.42,Ki,Binding affinity towards Alpha-1B adrenergic receptor in rat liver using [3H]prazosin as radioligand,CHEMBL,=,,,,,,,,,,Rattus norvegicus
183122,3514,3452,Sorbitol dehydrogenase,Enzyme,Q00796,SORD,DHSO_HUMAN,4.45,IC50,In vitro inhibitory activity against sorbitol dehydrogenase (SD) from sheep liver,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
185887,3294,1953,D(1A) dopamine receptor,GPCR,Q61616,Drd1,DRD1_MOUSE,6.12,IC50,Binding affinity against Dopamine receptor D1 was determined using [3H]SCH-23390 radioligand,CHEMBL,=,,,,,,,,,,Mus musculus
36346,1762,1709,Arachidonate 15-lipoxygenase,Enzyme,P12530,ALOX15,LOX15_RABIT,5.672,IC50,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DRUG MATRIX,=,,,,,,,,,,Oryctolagus cuniculus
169485,4112,92,Thyroid hormone receptor alpha,Nuclear hormone receptor,P10827,THRA,THA_HUMAN,4.229,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
219504,1557,214,Large neutral amino acids transporter small subunit 1,Transporter,Q01650,SLC7A5,LAT1_HUMAN,4.07,IC50,Cis-inhibition of human LAT1 expressed in TREx HEK293 cells at 200 uM assessed as inhibition of [3H]-gabapentin uptake preincubated for 3 mins at 37 degC followed by washing with choline buffer and measured after 3 hrs by scintillation counting analysis relative to BCH,CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
181078,1920,2604,Neuronal acetylcholine receptor subunit alpha-4,Ion channel,P09482,CHRNA4,ACHA4_CHICK,8.72,Ki,Binding affinity to recombinant Gallus gallus (chicken) alpha4beta2 nicotinic acetylcholine receptor assessed as [3H]NIC binding by radioligand binding assay,CHEMBL,=,,,,,,,,,,Gallus gallus
186202,1282,769,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",Kinase,Q16816,PHKG1,PHKG1_HUMAN,5.43,Kd,Binding constant for full-length PHKG1,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
223996,1969,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,4.46,Ki,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
185216,2544,2228,MAP/microtubule affinity-regulating kinase 4,Kinase,Q96L34,MARK4,MARK4_HUMAN,5.44,Kd,Binding constant for MARK4 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
184704,1353,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.33,Ki,Binding affinity to human cloned 5HT2C receptor,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
181368,2551,1802,Choline O-acetyltransferase,Enzyme,P32738,Chat,CLAT_RAT,9.82,Ki,Inhibition constant determined against Acetylcholinesterase (AChE) receptor.,CHEMBL,=,,,,,,,,,,Rattus norvegicus
184453,2179,2101,Peroxisome proliferator-activated receptor gamma,Transcription factor,O88275,Pparg,PPARG_RAT,6.15,IC50,Displacement of [3H]rosigliatzone from PPARgamma in rat adipocytes,CHEMBL,=,,,,,,,,,,Rattus norvegicus
219184,4718,4138,Glucagon-like peptide 2 receptor,GPCR,Q9Z0W0,Glp2r,GLP2R_RAT,10.1,EC50,Agonist activity at rat GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay,CHEMBL,=,,,,,,,,,,Rattus norvegicus
183343,2870,1852,Translocator protein,Membrane receptor,P16257,Tspo,TSPO_RAT,5.33,IC50,Displacement of Ro 5-4864 from peripheral (renal cell) Benzodiazepine receptor,CHEMBL,=,,,,,,,,,,Rattus norvegicus
26449,972,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,6.0,Ki,,IUPHAR,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
180858,3977,3526,Tyrosinase,Enzyme,P11344,Tyr,TYRO_MOUSE,4.21,IC50,Inhibition of catecholase activity of tyrosinase in mouse B16 cells assessed as dopachrome formation,CHEMBL,=,,,,,,,,,,Mus musculus
182142,2303,2893,Adrenergic receptor beta,GPCR,P10608|P18090|P26255,Adrb2|Adrb1|Adrb3,ADRB2_RAT|ADRB1_RAT|ADRB3_RAT,8.62,Ki,Inhibitory activity against beta adrenergic receptor of rat frontal cortex homogenate using (1.0 nM) [3H]- dihydroalprenolol,CHEMBL,=,,,,,,,,,,Rattus norvegicus
182953,2046,2834,Serotonin 3 receptor (5HT3),Ion channel,O95264|P46098,HTR3B|HTR3A,5HT3B_HUMAN|5HT3A_HUMAN,9.74,Kd,Binding affinity to human wild type 5-HT3A/5-HT3B receptor expressed in HEK293 cells after 24 hrs by liquid scintillation counting analysis,CHEMBL,=,,,,,,,Tchem|Tclin|Tchem|Tclin,,,Homo sapiens
35063,928,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,4.658,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
183732,1621,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.52,Ki,Binding affinity towards 5-hydroxytryptamine 2B receptor using [125I]DOI as radioligand,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
37781,2600,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,7.137,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
162659,2146,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,6.9,Ki,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1215,AGONIST,,Tclin,,,Homo sapiens
163292,1414,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
183242,1071,765,Glutathione S-transferase P,Enzyme,P09211,GSTP1,GSTP1_HUMAN,5.47,IC50,Inhibition of GST P1-1 in human HL60 cell lysate,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
182979,1962,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,6.92,IC50,Inhibitory concentration against recombinant rat androgen receptor expressed in Escherichia coli using [3H]methyltrienolone (R 1881),CHEMBL,=,,,,,,,,,,Rattus norvegicus
218944,5341,823,Ephrin type-A receptor 6,Kinase,Q9UF33,EPHA6,EPHA6_HUMAN,5.04,Kd,Binding constant for EPHA6 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
214997,5072,3691,SLAM family member 7,Membrane receptor,Q9NQ25,SLAMF7,SLAF7_HUMAN,8.05,Kd,,IUPHAR,=,1.0,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/761035s000lbl.pdf,ANTIBODY BINDING,1.0,Tclin,,493.0,Homo sapiens
164081,2168,292,Interleukin-2,Cytokine,P60568,IL2,IL2_HUMAN,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
34345,671,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.161,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
184590,258,1480,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,Q63707,Dhodh,PYRD_RAT,6.15,IC50,Inhibition of rat purified recombinant DHODH,CHEMBL,=,,,,,,,,,,Rattus norvegicus
184213,2026,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,Mechanism of Action; CHEMBL216; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1495,ANTAGONIST,,Tclin,,,Homo sapiens
224137,2544,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,5.52,IC50,Inhibition of ABCG2 (unknown origin) expressed in human SAOS-2 cells mediated Hoechst 33342 efflux preincubated with compound for 15 mins followed by substrate addition and measured after 45 mins using Hoechst 33342 as substrate by flow cytometry,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
163037,2695,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.64,Ki,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL770,ANTAGONIST,,Tclin,,,Homo sapiens
26778,3659,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,7.7,Ki,,IUPHAR,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
38293,4122,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.65,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37535,2495,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.786,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
38256,3972,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,5.891,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37486,2440,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,5.962,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
186745,785,2207,"Chaperone activity of bc1 complex-like, mitochondrial",Kinase,Q8NI60,COQ8A,COQ8A_HUMAN,6.72,Kd,Binding constant for ADCK3 kinase domain,CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
184173,2537,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,8.82,Kd,Affinity constant of compound was evaluated in rat striatum tissue preparation.,CHEMBL,=,,,,,,,,,,Rattus norvegicus
164936,2389,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,8.0,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
34926,885,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,8.1,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
224172,1937,559,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",Enzyme,Q08499,PDE4D,PDE4D_HUMAN,5.15,IC50,Inhibition of PDE4D (unknown origin) expressed in Escherichia coli BL21 [3H]-cAMP as substrate measured for 15 mins by liquid scintillation counter method,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
180887,1622,152,"Glutathione reductase, mitochondrial",Enzyme,P00390,GSR,GSHR_HUMAN,4.26,Ki,Competitive inhibition of human erythrocyte Glutathione reductase using GSSG substrate by Lineweaver-Burk plot analysis,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
224207,5353,2222,Tyrosine-protein kinase Blk,Kinase,P51451,BLK,BLK_HUMAN,8.95,IC50,Affinity Biochemical interaction (33P-ATP and filter-binding assay (Reaction Biology)) EUB0000646a BLK,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
188677,4682,2109,Histone deacetylase,Enzyme,Q9XYC7,HDAC1,Q9XYC7_PLAFA,8.74,IC50,Inhibition of Plasmodium falciparum HDAC1 expressed in Drosophila melanogaster S2 cells,CHEMBL,=,,,,,,,,,,Plasmodium falciparum
184834,2563,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.55,Ki,Binding affinity for DA2 receptor,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
27774,1427,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,5.237,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
186195,1282,824,TRAF2 and NCK-interacting protein kinase,Kinase,Q9UKE5,TNIK,TNIK_HUMAN,5.16,Kd,Binding constant for TNIK kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
27171,2865,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,5.456,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
165038,1007,62,Sodium channel subunit beta-1,Ion channel,Q07699,SCN1B,SCN1B_HUMAN,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
218856,5347,925,Testis-specific serine/threonine-protein kinase 1,Kinase,Q9BXA7,TSSK1B,TSSK1_HUMAN,5.89,Kd,Binding constant for TSSK1B kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
164112,2847,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,4.867,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
189075,4921,2875,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,P04774|P04775|P08104,Scn1a|Scn2a|Scn3a,SCN1A_RAT|SCN2A_RAT|SCN3A_RAT,5.09,IC50,Binding of [3H]batrachotoxin (BTX) to rat brain sodium channel,CHEMBL,=,,,,,,,,,,Rattus norvegicus
164734,407,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.1,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
183789,1419,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,7.0,IC50,Inhibition of human ERG,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
188021,4223,1847,5-hydroxytryptamine receptor 2C,GPCR,P08909,Htr2c,5HT2C_RAT,5.7,IC50,Inhibition of rat hydroxytryptamine 2C receptor,CHEMBL,=,,,,,,,,,,Rattus norvegicus
26557,109,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.0,Kd,,IUPHAR,=,,,,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
182398,518,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,4.89,IC50,Inhibition of ovine COX1 after 5 mins,CHEMBL,=,,,,,,,,,,Ovis aries
36595,1836,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,5.713,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
181698,1791,443,"Cytochrome P450 11B1, mitochondrial",Enzyme,P15538,CYP11B1,C11B1_HUMAN,7.84,IC50,Inhibition of human steroid-11beta-hydroxylase expressed in chinese hamster V79 cells using 11-deoxycorticosterone as substrate,CHEMBL,=,1.0,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/012911Orig1s033lbl.pdf,INHIBITOR,,Tclin,,368.0,Homo sapiens
187167,1548,695,Receptor tyrosine-protein kinase erbB-4,Kinase,Q15303,ERBB4,ERBB4_HUMAN,7.27,Kd,Binding constant for ERBB4 kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
222197,5280,2188,MAP kinase-interacting serine/threonine-protein kinase 1,Kinase,Q9BUB5,MKNK1,MKNK1_HUMAN,6.64,Kd,Binding constant for MKNK1 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
219981,2503,4918,"6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase",Unclassified,Q8IAU3,PF3D7_0810800,Q8IAU3_PLAF7,7.14,IC50,Parasite growth inhibition assay,IUPHAR,=,,,,,,,,,,Plasmodium falciparum (isolate 3D7)
184488,1440,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,9.85,EC50,Agonist activity at androgen receptor (unknown origin) expressed in HeLa cells co-expressing PSA-(ARE)4-Luc13 assessed as induction of DHT-induced luciferase activity after 20 mins by luciferase reporter gene assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
5299,2434,208,Lanosterol 14-alpha demethylase,Enzyme,P10613,ERG11,CP51_CANAL,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201196,INHIBITOR,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
183310,1153,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,6.09,Ki,Affinity towards Dopamine receptor D2,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
182131,1593,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.16,Ki,Displacement of [3H]RS-79948-197 from human adrenoceptor aplha 2C expressed in CHO cells,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
165253,4119,619,Histone deacetylase 3,Enzyme,O15379,HDAC3,HDAC3_HUMAN,7.604,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
216274,2846,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,4.89,IC50,,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
215692,2233,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,5.78,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
37241,2302,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,5.417,IC50,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
186563,3533,2230,Dual specificity mitogen-activated protein kinase kinase 6,Kinase,P52564,MAP2K6,MP2K6_HUMAN,5.41,Kd,Binding constant for MEK6 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
36776,1982,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.26,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
219294,4907,3727,Poly [ADP-ribose] polymerase 4,Enzyme,Q9UKK3,PARP4,PARP4_HUMAN,6.39,IC50,Inhibition of recombinant human His6-tagged PARP4 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay,CHEMBL,=,,,,,,,,,,Homo sapiens
218745,5347,2197,SRSF protein kinase 1,Kinase,Q96SB4,SRPK1,SRPK1_HUMAN,6.8,Kd,Binding constant for SRPK1 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
215767,2389,54,Beta-1 adrenergic receptor,GPCR,P08588,ADRB1,ADRB1_HUMAN,5.301,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
134565,4892,2059,Sodium/glucose cotransporter 1,Transporter,P13866,SLC5A1,SC5A1_HUMAN,5.073,IC50,,SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/22889351,,,,Tclin,10.0,,Homo sapiens
34385,671,1713,5-hydroxytryptamine receptor 1B,GPCR,P28564,Htr1b,5HT1B_RAT,6.658,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
219399,607,3544,Dihydrofolate reductase,Enzyme,P00376,DHFR,DYR_BOVIN,7.52,IC50,Inhibition of bovine liver DHFR,CHEMBL,=,,,,,,,,,,Bos taurus
36239,1688,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.721,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
185804,114,1759,Mu-type opioid receptor,GPCR,P97266,OPRM1,OPRM_CAVPO,7.82,IC50,In vitro binding activity against opioid receptor mu using [3H]DAGO) as radioligand,CHEMBL,=,,,,,,,,,,Cavia porcellus
188869,4903,2232,Calcium/calmodulin-dependent protein kinase type IV,Kinase,Q16566,CAMK4,KCC4_HUMAN,5.43,Kd,Binding constant for CAMK4 kinase domain,CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
163710,2729,2738,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,P14867|P18507|P28472,GABRA1|GABRG2|GABRB3,GBRA1_HUMAN|GBRG2_HUMAN|GBRB3_HUMAN,9.097,Ki,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL646,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
185877,945,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,7.93,Ki,Displacement of [3H]nemonapride from Rattus norvegicus (rat) wild type dopamine D3 receptor transfected in african green monkey COS7 cells after 1 hr by beta scintillation counting,CHEMBL,=,,,,,,,,,,Rattus norvegicus
183160,3514,1771,Adenosine receptor A1,GPCR,P25099,Adora1,AA1R_RAT,5.61,Ki,Displacement of specific [3H]PIA binding from adenosine A1 receptor in rat brain membranes.,CHEMBL,=,,,,,,,,,,Rattus norvegicus
187498,4124,575,Histone deacetylase 5,Enzyme,Q9UQL6,HDAC5,HDAC5_HUMAN,7.48,Ki,Inhibition of HDAC5,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
182035,1145,1784,Prostaglandin G/H synthase 1,Enzyme,P05979,PTGS1,PGH1_SHEEP,5.41,IC50,Inhibition of ovine COX1 by enzyme-immuno assay,CHEMBL,=,,,,,,,,,,Ovis aries
164976,2637,82,D(1A) dopamine receptor,GPCR,P21728,DRD1,DRD1_HUMAN,7.1,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
187651,4178,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,6.44,Kd,Binding constant for FYN kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
186089,1212,2862,Adenylate cyclase,Enzyme,D4A3N4|P21932|P26769|P26770|P40146|Q03343|Q04400|Q8CFM9,Adcy1|Adcy3|Adcy2|Adcy4|Adcy8|Adcy6|Adcy5,D4A3N4_RAT|ADCY3_RAT|ADCY2_RAT|ADCY4_RAT|ADCY8_RAT|ADCY6_RAT|ADCY5_RAT|Q8CFM9_RAT,7.1,IC50,The compound was tested for adenylate cyclase activity in rat corpus striatum,CHEMBL,=,,,,,,,,,,Rattus norvegicus
181002,947,1824,Beta-2 adrenergic receptor,GPCR,P54833,ADRB2,ADRB2_CANFA,4.3,Ki,Binding of [3H]dihydroalprenolol to beta-2 adrenergic receptor of rat cerebral cortical membranes,CHEMBL,=,,,,,,,,,,Canis familiaris
188607,4630,344,Farnesyl pyrophosphate synthase,Enzyme,P14324,FDPS,FPPS_HUMAN,4.53,Ki,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
187645,4178,2196,Serine/threonine-protein kinase SIK2,Kinase,Q9H0K1,SIK2,SIK2_HUMAN,6.37,Kd,Binding constant for full-length SNF1LK2,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
182287,228,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,8.59,Ki,Displacement of [3H]domperidone from human cloned dopamine D3 receptor expressed in mouse CCL1-3 cells by scintillation counting,CHEMBL,=,,,,,AGONIST,,Tclin,,,Homo sapiens
218828,5347,2320,Interleukin-1 receptor-associated kinase 4,Kinase,Q9NWZ3,IRAK4,IRAK4_HUMAN,5.92,Kd,Binding constant for IRAK4 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
26030,2605,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,8.6,Ki,,IUPHAR,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
170685,1646,3386,Neuronal acetylcholine receptor subunit alpha-6,Ion channel,Q15825,CHRNA6,ACHA6_HUMAN,4.96,IC50,,IUPHAR,=,,,,,BLOCKER,,Tchem,,,Homo sapiens
37789,2600,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.292,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37297,2337,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.457,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
221913,4801,2355,Serine/threonine-protein kinase ULK1,Kinase,O75385,ULK1,ULK1_HUMAN,6.73,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
186244,1751,276,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,Q07422,,DRTS_TOXGO,8.85,IC50,Inhibitory activity against Dihydrofolate reductase from Toxoplasma gondii was evaluated using 90 uM dihydrofolic acid as substrate,CHEMBL,=,,,,,,,,,,Toxoplasma gondii
185868,2239,238,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P04035,HMGCR,HMDH_HUMAN,7.52,IC50,Tested in vitro for the inhibition of HMG-CoA reductase from partially purified microsomal preparations.,CHEMBL,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1144,INHIBITOR,,Tclin,,,Homo sapiens
188575,4573,2420,Dihydrofolate reductase,Enzyme,P0A017,folA,DYR_STAAU,10.1,Ki,Inhibition of Staphylococcus aureus DHFR using dihydrofolate as substrate preincubated for 10 mins followed by substrate addition by spectrophotometric analysis in presence of NADPH,CHEMBL,=,,,,,,,,,,Staphylococcus aureus
216630,2599,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,4.88,IC50,,CHEMBL,=,,,,,,,,,,Rattus norvegicus
36576,1821,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,5.691,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
224010,2350,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,5.07,IC50,Inhibition of human ABCG2 expressed in human HEK293 cells membrane vesicles mediated transport of 3[H]-MTX for 2 mins using [3H]-methotrexate as substrate by rapid filtration technique,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
163772,1076,2796,GABA A receptor alpha-4/beta-2/delta,Ion channel,O14764|P47870|P48169,GABRD|GABRB2|GABRA4,GBRD_HUMAN|GBRB2_HUMAN|GBRA4_HUMAN,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
181359,2551,1799,Acetylcholinesterase,Enzyme,P23795,ACHE,ACES_BOVIN,7.4,Ki,Inhibition of fetal Bovine serum AChE,CHEMBL,=,,,,,,,,,,Bos taurus
187034,1932,2461,Dual specificity mitogen-activated protein kinase kinase 5,Kinase,Q13163,MAP2K5,MP2K5_HUMAN,6.72,Kd,Binding constant for MEK5 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
182732,658,371,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,Q07869,PPARA,PPARA_HUMAN,6.05,EC50,Transactivation of GAL4-fused PPARalpha LBD expressed in HepG2 cells after 20 hrs by luminescence assay,CHEMBL,=,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/15123680,AGONIST,,Tclin,,475.0,Homo sapiens
185657,2740,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.82,Ki,Affinity for sigma receptor type 1 of guinea pig using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
182383,1057,500,Steryl-sulfatase,Enzyme,P08842,STS,STS_HUMAN,4.08,IC50,Inhibition of steroid sulfatase activity of JEG-3 cells,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
215659,1150,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,6.176,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
216945,331,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.264,Ki,,SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/22711801,,,,Tclin,659.0,,Homo sapiens
181761,2492,2392,Beta-lactamase,Enzyme,Q7X575,SHV-11,Q7X575_ECOLX,5.62,IC50,Inhibition of Escherichia coli JM109 beta-lactamase SHV-11,CHEMBL,=,,,,,,,,,,Escherichia coli
186109,2435,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,7.96,Ki,Displacement of [3H]-YM-09151-2 (0.06 nM) from human Dopamine receptor D4 expressed in CHO cells,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
216285,829,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,5.85,Ki,,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
221760,5280,670,Rho-associated protein kinase 1,Kinase,Q13464,ROCK1,ROCK1_HUMAN,6.23,Kd,Binding constant for ROCK1 kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
183759,949,2055,Carbonic anhydrase 13,Enzyme,Q8N1Q1,CA13,CAH13_HUMAN,7.74,Ki,Inhibition of human carbonic anhydrase13 preincubated for 15 mins by stopped-flow CO2 hydration assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
222508,5209,901,STE20-like serine/threonine-protein kinase,Kinase,Q9H2G2,SLK,SLK_HUMAN,5.98,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
181402,2439,1692,Potassium channel subfamily K member 18,Ion channel,Q7Z418,KCNK18,KCNKI_HUMAN,,,Mechanism of Action; CHEMBL2331042; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200694,OPENER,,Tclin,,,Homo sapiens
216933,5221,3714,Programmed cell death 1 ligand 1,CD molecules,Q9NZQ7,CD274,PD1L1_HUMAN,,,,UNKNOWN,,1.0,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761049s000lbl.pdf,ANTIBODY BINDING,,Tclin,,654.0,Homo sapiens
216748,1830,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,7.48,Ki,,CHEMBL,=,,,,,,,,,,Rattus norvegicus
187534,4167,1548,Sphingosine-1-phosphate lyase 1,Enzyme,O95470,SGPL1,SGPL1_HUMAN,4.77,IC50,Inhibition of human recombinant S1PL (62 to 568) expressed in Sf9 insect cells using S1P as substrate after 1 hr,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
215475,4109,200,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,5.89,EC50,,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
184172,2537,400,Carbonic anhydrase 7,Enzyme,P43166,CA7,CAH7_HUMAN,8.44,Ki,Inhibition of human recombinant carbonic anhydrase 7 preincubated for 15 mins by stopped flow CO2 hydration assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
221706,4716,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.11,IC50,Inhibition of human ERG incubated for 4 hrs by competitive fluorescence tracer binding based assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
215508,4314,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.1,EC50,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
170534,4923,3394,Programmed cell death protein 1,Membrane receptor,Q15116,PDCD1,PDCD1_HUMAN,9.14,Kd,,IUPHAR,=,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/24872026,https://pubmed.ncbi.nlm.nih.gov/24872026,ANTIBODY BINDING,,Tclin,129.0,129.0,Homo sapiens
36913,2090,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.287,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
181180,2302,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRG2|GABRB2,GBRA1_HUMAN|GBRG2_HUMAN|GBRB2_HUMAN,5.7,EC50,Potentiation of GABA responses at human Gamma-aminobutyric acid A receptor alpha-1-beta-2-gamma-2,CHEMBL,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL526,POSITIVE ALLOSTERIC MODULATOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
189111,4985,620,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,,,Mechanism of Action,DRUG LABEL,,1.0,DRUG LABEL,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021536s031s051lbl.pdf,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021536s031s051lbl.pdf,AGONIST,,Tclin,266.0,266.0,Homo sapiens
222880,1328,519,Aspartyl/asparaginyl beta-hydroxylase,Enzyme,Q12797,ASPH,ASPH_HUMAN,6.6,IC50,"Inhibition of N-His6-tagged human AspH (315-755) expressed in Escherichia coli BL21 (DE3) using 1 uM hFX-CP as substrate mixture with 3 uM 2OG, 100 uM L-ascorbic acid and 2 uM FAS incubated for 35 mins by MS analysis",CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
217636,4458,1807,Endothelin-1 receptor,GPCR,P26684,Ednra,EDNRA_RAT,6.11,IC50,Antagonism of [125 I]ET-1 binding to the rat endothelin receptor in vascular smooth muscle VSM-A10 cells.,CHEMBL,=,,,,,,,,,,Rattus norvegicus
162605,1679,199,"Glutamate receptor ionotropic, NMDA 3A",Ion channel,Q8TCU5,GRIN3A,NMD3A_HUMAN,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1699,NEGATIVE ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
38225,3952,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,7.824,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL420,AGONIST,,Tclin,,,Homo sapiens
183481,2361,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,7.22,Ki,In vitro competitive binding versus [N-methyl-3H]WIN-35428 in murine kidney cells transfected with cDNA for human dopamine transporter (DAT),CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
188685,4683,1955,Cannabinoid receptor 1,GPCR,P47746,Cnr1,CNR1_MOUSE,5.92,IC50,Displacement of [3H]CP-55940 from CB1 receptor in mouse brain,CHEMBL,=,,,,,,,,,,Mus musculus
217454,1588,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,9.3,Ki,,IUPHAR,=,,,,,AGONIST,,,,,Rattus norvegicus
36510,1800,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,6.58,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
26379,972,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.4,Ki,,IUPHAR,=,,,,,ANTAGONIST,,Tchem,,,Homo sapiens
219986,672,4915,Short transient receptor potential channel 3,Ion channel,Q13507,TRPC3,TRPC3_HUMAN,5.04,IC50,,IUPHAR,=,,,,,BLOCKER,,Tchem,,,Homo sapiens
188331,4359,574,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",Kinase,P15735,PHKG2,PHKG2_HUMAN,5.89,Kd,Binding constant for PHKG2 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
220400,73,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,,,,DRUGBANK,,1.0,DRUGBANK,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL39560,ANTAGONIST,,Tclin,,,Homo sapiens
36758,1971,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,7.523,Ki,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
164126,2825,266,Multidrug resistance-associated protein 7,Transporter,Q5T3U5,ABCC10,MRP7_HUMAN,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
222929,5288,4047,Transient receptor potential cation channel subfamily A member 1,Ion channel,Q6RI86,Trpa1,TRPA1_RAT,6.35,IC50,Antagonist activity at rat TRPA1 expressed in HEK293 cells assessed as inhibition of allylisothiocyanate-induced Ca2+ response preincubated for 5 mins followed by allylisothiocyanate addition by Fluo-4AM dye based fluorescence assay,CHEMBL,=,,,,,,,,,,Rattus norvegicus
217922,5252,892,Cyclin-dependent kinase 16,Kinase,Q00536,CDK16,CDK16_HUMAN,5.64,Kd,Binding constant for PCTK1 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
26401,1865,129,Beta-3 adrenergic receptor,GPCR,P13945,ADRB3,ADRB3_HUMAN,6.3,Ki,,IUPHAR,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
216247,215,329,Corticosteroid-binding globulin,Secreted,P08185,SERPINA6,CBG_HUMAN,5.76,Ki,,CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
162404,1999,472,Sodium channel protein type 10 subunit alpha,Ion channel,Q9Y5Y9,SCN10A,SCNAA_HUMAN,5.201,IC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL900,BLOCKER,,Tclin,,,Homo sapiens
182178,1971,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.67,Ki,Displacement of [3H]LSD from human 5HT6 receptor expressed in HEK293 cells after 1.5 hrs by liquid scintillation counting,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
215559,623,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9.367,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
221293,1797,5335,Sodium channel protein type 4 subunit alpha,Ion channel,P15390,Scn4a,SCN4A_RAT,6.3,IC50,Inhibition of rat skeletal muscle Nav1.4 expressed in HEK293 cells by whole cell voltage clamp method,CHEMBL,=,,,,,,,,,,Rattus norvegicus
94116,574,2468,Tyrosine-protein phosphatase non-receptor type 7,Enzyme,P35236,PTPN7,PTN7_HUMAN,6.04,IC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
184485,1440,2892,Prostaglandin G/H synthase (cyclooxygenase),Enzyme,P05979|P79208,PTGS1|PTGS2,PGH1_SHEEP|PGH2_SHEEP,6.82,IC50,Inhibition of ram seminal vesicle Cyclooxygenase,CHEMBL,=,,,,,,,,,,Ovis aries
3354,1013,195,DNA gyrase subunit A,Enzyme,P43700,gyrA,GYRA_HAEIN,,,,WOMBAT-PK,,,,,,,,,,,Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd)
217876,5231,2334,Homeodomain-interacting protein kinase 2,Kinase,Q9H2X6,HIPK2,HIPK2_HUMAN,5.51,Kd,Binding affinity to HIPK2,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
217018,765,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,6.9,Ki,,IUPHAR,=,,,,,ANTAGONIST,,,,,Rattus norvegicus
217792,5231,744,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,6.25,Kd,Binding constant for MET(Y1235D) kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
164611,458,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
184344,1594,2781,DNA gyrase,Enzyme,P0AES4|P0AES6,gyrA|gyrB,GYRA_ECOLI|GYRB_ECOLI,,,Mechanism of Action; CHEMBL2311224; PROTEIN COMPLEX,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL561,INHIBITOR,,,,,Escherichia coli (strain K12)
165989,191,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
182223,1816,1748,D(2) dopamine receptor,GPCR,P61169,Drd2,DRD2_RAT,5.84,Ki,The binding affinity at the Dopamine receptor D2 determined using [3H]spiperone,CHEMBL,=,,,,,,,,,,Rattus norvegicus
165462,109,252,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,P36544,CHRNA7,ACHA7_HUMAN,5.959,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
219943,2382,3291,Short transient receptor potential channel 5,Ion channel,Q9UL62,TRPC5,TRPC5_HUMAN,5.04,EC50,,IUPHAR,=,,,,,ACTIVATOR,,Tchem,,,Homo sapiens
183208,3514,2886,Glycogen synthase kinase-3,Kinase,P49840|P49841,GSK3A|GSK3B,GSK3A_HUMAN|GSK3B_HUMAN,5.68,IC50,Inhibition of glycogen synthase kinase 3,CHEMBL,=,,,,,,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
221228,158,5410,Acid-sensing ion channel 1,Ion channel,P55926,Asic1,ASIC1_RAT,4.52,IC50,Inhibition of ASIC1 in Sprague-Dawley rat articular chondrocytes assessed as decrease in acid-induced intracellular calcium level by Fluo-3AM dye based laser scanning confocal microscopy,CHEMBL,=,,,,,,,,,,Rattus norvegicus
38173,3408,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,5.728,Ki,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
182466,2763,1735,Histamine H1 receptor,GPCR,P31389,HRH1,HRH1_CAVPO,9.9,Kd,Potency against histamine H1 receptor on guinea pig ileum,CHEMBL,=,,,,,,,,,,Cavia porcellus
219424,4877,2428,Carbonic anhydrase 2,Enzyme,Q3I4V7,CAN2,Q3I4V7_CRYNV,7.05,Ki,Inhibition of Cryptococcus neoformans Can2 incubated for 15 mins prior to testing by stopped flow CO2 hydrase assay,CHEMBL,=,,,,,,,,,,Cryptococcus neoformans var. grubii
221878,2561,615,Glucosylceramidase,Enzyme,P04062,GBA,GLCM_HUMAN,5.6,EC50,Chaperone activity at GCase in wild-type human fibroblasts assessed as increase in GPN-induced reduction of calcium release using Fluo-8AM based fluorescence assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
35313,977,535,Tyrosine-protein kinase Fyn,Kinase,P06241,FYN,FYN_HUMAN,6.091,IC50,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
162582,3483,208,Lanosterol 14-alpha demethylase,Enzyme,P10613,ERG11,CP51_CANAL,9.398,MIC,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1397,INHIBITOR,,,,,Candida albicans (strain SC5314 / ATCC MYA-2876)
186689,2406,1796,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,P51639,Hmgcr,HMDH_RAT,8.68,IC50,Inhibition of HMG-CoA reductase in rat liver microsomes,CHEMBL,=,,,,,,,,,,Rattus norvegicus
217456,180,1777,5-hydroxytryptamine receptor 7,GPCR,P32305,Htr7,5HT7R_RAT,7.0,Ki,,IUPHAR,=,,,,,ANTAGONIST,,,,,Rattus norvegicus
134542,4168,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,9.328,Ki,Mechanism of Action,DRUG LABEL,=,1.0,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/200603s015lbl.pdf,ANTAGONIST,,Tclin,,180.0,Homo sapiens
186765,785,745,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,9.24,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,,,INHIBITOR,,Tclin,,,Homo sapiens
35962,1527,111,Histamine H2 receptor,GPCR,P25021,HRH2,HRH2_HUMAN,4.667,Ki,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
188819,4866,808,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,6.59,IC50,Inhibition of FGFR2 (unknown origin) after 60 mins,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
217180,2538,4068,Prostaglandin E2 receptor EP3 subtype,GPCR,P34980,Ptger3,PE2R3_RAT,9.38,EC50,,IUPHAR,=,,,,,AGONIST,,,,,Rattus norvegicus
218256,5333,4253,B-cell antigen receptor complex-associated protein beta chain,Tumour-associated antigen,P40259,CD79B,CD79B_HUMAN,,,Mechanism of Action,UNKNOWN,,1.0,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761121s000lbl.pdf,ANTIBODY BINDING,,Tclin,,2593.0,Homo sapiens
35855,1364,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.636,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
217320,5240,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,8.081,IC50,,SCIENTIFIC LITERATURE,=,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/14761182,https://pubmed.ncbi.nlm.nih.gov/22278334,INHIBITOR,,Tclin,672.0,675.0,Homo sapiens
186512,3533,856,Serine/threonine-protein kinase pim-2,Kinase,Q9P1W9,PIM2,PIM2_HUMAN,6.89,Kd,Average Binding Constant for PIM2; NA=Not Active at 10 uM,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
217445,888,2011,5-hydroxytryptamine receptor 6,GPCR,P31388,Htr6,5HT6R_RAT,8.3,Ki,,IUPHAR,=,,,,,ANTAGONIST,,,,,Rattus norvegicus
208154,2852,662,Tissue-type plasminogen activator,Enzyme,P00750,PLAT,TPA_HUMAN,5.82,Ki,Inhibition of human t-PA,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
181495,3369,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1b|Adra1d|Adra1a,ADA1B_RAT|ADA1D_RAT|ADA1A_RAT,7.92,EC50,Compound was evaluated for Adrenergic activity against Alpha-1 adrenergic receptor from rat aorta,CHEMBL,=,,,,,,,,,,Rattus norvegicus
187588,4178,2068,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,5.77,Kd,Binding constant for BTK kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
38186,3487,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.199,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
187730,4187,736,Ephrin type-A receptor 8,Kinase,P29322,EPHA8,EPHA8_HUMAN,6.55,Kd,Binding constant for EPHA8 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
186717,785,2871,MAP kinase p38,Kinase,O15264|P53778|Q15759|Q16539,MAPK13|MAPK12|MAPK11|MAPK14,MK13_HUMAN|MK12_HUMAN|MK11_HUMAN|MK14_HUMAN,7.0,IC50,Inhibition of p38 kinase,CHEMBL,=,,,,,,,Tchem|Tchem|Tchem|Tchem|Tchem|Tchem|Tchem|Tchem|Tchem|Tchem|Tchem|Tchem|Tchem|Tchem|Tchem|Tchem,,,Homo sapiens
186693,1349,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,,,Mechanism of Action; CHEMBL2034; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200908,AGONIST,,Tclin,,,Homo sapiens
216599,1794,137,Sodium channel protein type 1 subunit alpha,Ion channel,P35498,SCN1A,SCN1A_HUMAN,4.96,IC50,,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
164389,1937,148,Adenosine receptor A3,GPCR,P0DMS8,ADORA3,AA3R_HUMAN,5.072,Ki,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
164906,1982,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.74,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
200268,2052,2819,Acetylcholine receptor; alpha1/beta1/delta/gamma,Ion channel,P02708|P07510|P11230|Q07001,CHRNA1|CHRNG|CHRNB1|CHRND,ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHD_HUMAN,7.09,IC50,GRAC: human AChR-alpha1 commonly used antagonist,CHEMBL,=,,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
184777,568,2285,Alpha carbonic anhydrase,Enzyme,B5SU02,CA,B5SU02_9CNID,7.47,Ki,Inhibition of cloned Stylophora pistillata alpha-CA expressed in human HEK293 cells by stopped-flow CO2 assay,CHEMBL,=,,,,,,,,,,Stylophora pistillata
182421,2159,1773,Acetylcholinesterase,Enzyme,P21836,Ache,ACES_MOUSE,9.17,IC50,Inhibitory activity against acetylcholinesterase,CHEMBL,=,,,,,,,,,,Mus musculus
217231,3580,426,Retinoic acid receptor beta,Nuclear hormone receptor,P10826,RARB,RARB_HUMAN,6.63,EC50,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
224199,4872,475,Flavin reductase (NADPH),Enzyme,P30043,BLVRB,BLVRB_HUMAN,6.7,Kd,Binding affinity to human N-terminal His6-tagged and thrombin cleavage fused BLVRB expressed in Escherichia coli BL21 (DE3) assessed as dissociation constant by isothermal titration calorimetry,CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
223743,5739,3515,Complement C5,Secreted,P01031,C5,CO5_HUMAN,,,Mechanism of Action,UNKNOWN,=,1.0,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217225s000lbl.pdf,INHIBITOR,,Tclin,,3699.0,Homo sapiens
34459,701,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.337,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
219682,5371,4571,Alpha-ketoglutarate-dependent dioxygenase FTO,Unclassified,Q9C0B1,FTO,FTO_HUMAN,5.01,IC50,Inhibition of human hexahistidine-tagged full-length FTO expressed in Escherichia coli BL21 (DE3) using 3-methylthymidine as substrate assessed as inhibition of 3-methylthymidine conversion to thymidine after 1 hr by liquid chromatographic analysis,CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
217145,2042,1971,Vasopressin V1a receptor,GPCR,P30560,Avpr1a,V1AR_RAT,6.1,Ki,,IUPHAR,=,,,,,AGONIST,,,,,Rattus norvegicus
164843,2436,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.38,Kd,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
185161,2544,2248,Serine/threonine-protein kinase DCLK1,Kinase,O15075,DCLK1,DCLK1_HUMAN,6.43,Kd,Binding constant for DCAMKL1 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
162353,564,2501,Penicillin-binding protein 2,Enzyme,P0AD65,mrdA,PBP2_ECOLI,6.213,IC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200995,INHIBITOR,,,,,Escherichia coli (strain K12)
221412,5487,3193,Growth hormone secretagogue receptor type 1,GPCR,Q92847,GHSR,GHSR_HUMAN,8.14,IC50,Anamorelin  competitively  inhibited  the  binding  of  human  ghrelin  to  GHS-R1a,DRUG LABEL,=,1.0,DRUG LABEL,https://www.pmda.go.jp/files/000242929.pdf,https://www.pmda.go.jp/files/000242929.pdf,AGONIST,1.0,Tclin,3263.0,3263.0,Homo sapiens
216628,887,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,8.79,IC50,,CHEMBL,=,,,,,,,,,,Rattus norvegicus
183373,2787,1797,M1 family aminopeptidase,Enzyme,O96935,,AMP1_PLAFQ,6.72,Ki,Inhibition of Plasmodium falciparum recombinant M1-aminopeptidase expressed in Escherichia coli after 40 mins uisng fluorogenic substrate L-Leucyl-7-amido-40-methylcoumarin by fluorescence spectrophotometry,CHEMBL,=,,,,,,,,,,Plasmodium falciparum (isolate FcB1 / Columbia)
180836,1497,2593,Dihydrofolate reductase,Enzyme,P9WNX1,folA,DYR_MYCTU,9.0,Ki,Inhibition of Mycobacterium tuberculosis dihydrofolate reductase,CHEMBL,=,,,,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
162774,403,131,5-hydroxytryptamine receptor 1D,GPCR,P28221,HTR1D,5HT1D_HUMAN,8.0,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
186132,2767,1816,Amine oxidase [flavin-containing] B,Enzyme,P19643,Maob,AOFB_RAT,4.96,Ki,Uncompetitive inhibition of rat MAOB expressed in Pichia pastoris,CHEMBL,=,,,,,,,,,,Rattus norvegicus
215100,5133,3486,Apoptosis regulator Bcl-W,Cytosolic other,Q92843,BCL2L2,B2CL2_HUMAN,6.611,Ki,,SCIENTIFIC LITERATURE,=,,,https://pubmed.ncbi.nlm.nih.gov/23291630,,INHIBITOR,,Tchem,583.0,,Homo sapiens
183634,3025,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.73,Ki,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
36979,2123,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,6.097,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
27245,2639,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,6.821,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
34352,671,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.036,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
184365,2742,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,5.13,IC50,Inhibition of Equine serum BChE using butyrylthiocholine iodide as a substrate after 20 mins by Ellman's assay,CHEMBL,=,,,,,,,,,,Equus caballus
185211,2544,2338,Serine/threonine-protein kinase ICK,Kinase,Q9UPZ9,ICK,ICK_HUMAN,6.33,Kd,Binding affinity to ICK,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
219309,285,2077,Cholinesterase,Enzyme,P81908,BCHE,CHLE_HORSE,6.92,IC50,Inhibition of equine serum BuChE using S-butyrylthiocholine iodide as substrate preincubated for 60 mins followed by substrate addition measured after 5 mins by Ellman's method,CHEMBL,=,,,,,,,,,,Equus caballus
219757,5244,4558,Nonstructural protein 5A,Unclassified,Q5L478,NS5A,Q5L478_9HEPC,10.19,EC50,Inhibition of NS5A in HuH7 cell infected HCV genotype 1a H77 assessed as decrease in viral replication after 3 days in presence of 40% human plasma by luciferase reporter gene assay,CHEMBL,=,,,,,,,,,,Hepatitis C virus
185934,1805,3607,P-glycoprotein 3,Transporter,P21447,Abcb1a,MDR1A_MOUSE,4.7,Kd,Compound was tested for the binding affinity towards recombinant NBD2 C-terminal cytotoxic nucleotide-binding domain of mouse P-Glycoprotein,CHEMBL,=,,,,,,,,,,Mus musculus
219774,2646,4522,Macrophage migration inhibitory factor,Unclassified,P14174,MIF,MIF_HUMAN,4.8,IC50,Inhibition of recombinant human MIF expressed in Escherichia coli BL21(DE3) using L-dopa as substrate,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
217153,2144,4075,Probable G-protein coupled receptor 139,GPCR,Q6DWJ6,GPR139,GP139_HUMAN,4.51,IC50,Measured using a GTP&gamma;S assay in transfected COS7 cells.,IUPHAR,=,,,,,AGONIST,,,,,Homo sapiens
216590,1310,1996,Metabotropic glutamate receptor 6,GPCR,P35349,Grm6,GRM6_RAT,4.8,EC50,,CHEMBL,=,,,,,,,,,,Rattus norvegicus
184021,1129,2514,Solute carrier family 22 member 3,Transporter,O75751,SLC22A3,S22A3_HUMAN,4.97,IC50,Inhibition of human OCT3-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
27595,1971,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.921,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
222609,4866,789,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,5.15,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
216868,5155,924,G-protein coupled bile acid receptor 1,GPCR,Q8TDU6,GPBAR1,GPBAR_HUMAN,7.0,EC50,,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
222482,4942,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,5.42,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
37323,2338,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.558,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
221294,2001,5482,Neuraminidase,Enzyme,Q6XV28,,NRAM_I77AG,7.82,IC50,Inhibition of Influenza A virus A/duck/Guangdong/674/2014(H5N6) neuraminidase N6 using fluorogenic MUNANA as substrate preincubated for 10 mins followed by substrate addition measured after 40 to 60 mins by fluorescence-based assay,CHEMBL,=,,,,,,,,,,Influenza A virus
164385,816,154,Gamma-aminobutyric acid type B receptor subunit 2,GPCR,O75899,GABBR2,GABR2_HUMAN,8.027,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
215448,134,265,Bile salt export pump,Transporter,O95342,ABCB11,ABCBB_HUMAN,5.04,IC50,,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
33894,249,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.733,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
189064,4903,1945,Glycogen synthase kinase-3 alpha,Kinase,P49840,GSK3A,GSK3A_HUMAN,6.37,Kd,Binding constant for GSK3A kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
217964,5231,2088,Ribosomal protein S6 kinase beta-1,Kinase,P23443,RPS6KB1,KS6B1_HUMAN,5.89,Kd,Binding constant for S6K1 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
215921,1637,3891,Cytoplasmic zinc-finger protein,Unclassified,G5EF15,pos-1,G5EF15_CAEEL,4.58,EC50,Active,CHEMBL,=,,,,,,,,,,Caenorhabditis elegans
182056,256,1754,Sodium-dependent dopamine transporter,Transporter,P23977,Slc6a3,SC6A3_RAT,5.85,Ki,Inhibition of [3H]- DA reuptake into rat striatal synaptosomes,CHEMBL,=,,,,,,,,,,Rattus norvegicus
182045,1899,2845,Cyclooxygenase,Enzyme,P35355|Q63921,Ptgs2|Ptgs1,PGH2_RAT|PGH1_RAT,7.0,IC50,Inhibitory activity against Prostaglandin G/H synthase,CHEMBL,=,,,,,,,,,,Rattus norvegicus
222322,4715,2461,Dual specificity mitogen-activated protein kinase kinase 5,Kinase,Q13163,MAP2K5,MP2K5_HUMAN,5.62,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
219069,949,4130,"Carbonic anhydrase, alpha family",Unclassified,Q31FD6,,Q31FD6_HYDCU,8.15,Ki,Inhibition of recombinant Thiomicrospira crunogena XCL-2 carbonic anhydrase by stopped flow CO2 hydrase assay,CHEMBL,=,,,,,,,,,,Hydrogenovibrio crunogenus (strain XCL-2)
164967,406,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,7.85,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
219758,4912,4558,Nonstructural protein 5A,Unclassified,Q5L478,NS5A,Q5L478_9HEPC,10.85,EC50,Inhibition of NS5A in HuH7 cell infected HCV genotype 1a H77 assessed as decrease in viral replication after 3 days by luciferase reporter gene assay,CHEMBL,=,,,,,,,,,,Hepatitis C virus
185192,2544,2344,Microtubule-associated serine/threonine-protein kinase 1,Kinase,Q9Y2H9,MAST1,MAST1_HUMAN,6.7,Kd,Binding affinity to MAST1,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
164693,1342,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
162779,128,130,5-hydroxytryptamine receptor 1B,GPCR,P28222,HTR1B,5HT1B_HUMAN,8.0,Ki,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1505,AGONIST,,Tclin,,,Homo sapiens
27381,2436,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.721,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
182210,1796,1865,D(3) dopamine receptor,GPCR,P19020,Drd3,DRD3_RAT,5.82,Ki,Tested for binding affinity against dopamine receptor D3 expressed in Sf9 cells.,CHEMBL,=,,,,,,,,,,Rattus norvegicus
183403,1728,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,5.96,IC50,Binding affinity against delta-opiate receptor (human) using [3H]-DPDPE radioligand,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
163366,956,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,6.79,EC50,,WOMBAT-PK,=,,,,,,,Tchem,,,Homo sapiens
36977,2123,268,Cytochrome P450 2C9,Enzyme,P11712,CYP2C9,CP2C9_HUMAN,5.398,IC50,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
185962,1115,1743,Reverse transcriptase/RNaseH,Enzyme,Q72547,pol,Q72547_9HIV1,9.22,IC50,Inhibition of HIV1 isolate R8 reverse transcriptase after 90 mins,CHEMBL,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL308954,INHIBITOR,,,,,Human immunodeficiency virus 1
171345,4223,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,7.15,IC50,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
37087,2274,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.721,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
183907,2068,2607,P2X purinoceptor 4,Ion channel,Q99571,P2RX4,P2RX4_HUMAN,5.33,IC50,Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx preincubated for 30 mins followed by ATP addition by Fluo-4 AM dye-based fluorescence assay,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
187584,4178,2283,Ribosomal protein S6 kinase alpha-1,Kinase,Q15418,RPS6KA1,KS6A1_HUMAN,6.4,Kd,Binding constant for RPS6KA1(Kin.Dom.2 - C-terminal) kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
170869,2781,854,Small conductance calcium-activated potassium channel protein 2,Ion channel,Q9H2S1,KCNN2,KCNN2_HUMAN,5.7,IC50,,IUPHAR,=,,,,,BLOCKER,,Tchem,,,Homo sapiens
222589,4867,541,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,8.15,IC50,Inhibition of VEGFR1 (unknown origin),CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
28016,672,112,Histamine H4 receptor,GPCR,Q9H3N8,HRH4,HRH4_HUMAN,6.396,Ki,,PDSP,=,,,,,,,Tchem,,,Homo sapiens
187869,4190,538,Serine/threonine-protein kinase B-raf,Kinase,P15056,BRAF,BRAF_HUMAN,5.66,Kd,Binding constant for BRAF kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
216914,314,2516,Zinc finger protein mex-5,Cytosolic other,Q9XUB2,mex-5,MEX5_CAEEL,6.95,EC50,Active,CHEMBL,=,,,,,,,,,,Caenorhabditis elegans
184368,913,143,Prostaglandin E2 receptor EP1 subtype,GPCR,P34995,PTGER1,PE2R1_HUMAN,8.04,Ki,Displacement of [3H]PGE2 from human EP1 receptor expressed in HEK293 cells,CHEMBL,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL548,AGONIST,,Tclin,,,Homo sapiens
37764,2599,49,Sodium/nucleoside cotransporter 1,Transporter,O00337,SLC28A1,S28A1_HUMAN,5.373,Ki,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),DRUG MATRIX,=,,,,,,,Tbio,,,Homo sapiens
185305,2544,745,Tyrosine-protein kinase Lyn,Kinase,P07948,LYN,LYN_HUMAN,6.57,Kd,Binding constant for LYN kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
162415,3862,426,Retinoic acid receptor beta,Nuclear hormone receptor,P10826,RARB,RARB_HUMAN,7.3,EC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL705,AGONIST,,Tclin,,,Homo sapiens
186092,2761,96,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,7.96,Ki,Affinity for human EMP expressed in ERG2 deficient strain of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine as radioligand,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
37804,2607,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,5.837,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
187180,888,2495,Multidrug and toxin extrusion protein 2,Transporter,Q86VL8,SLC47A2,S47A2_HUMAN,4.9,IC50,Inhibition of human MATE2K-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
217814,5231,868,Tyrosine-protein kinase FRK,Kinase,P42685,FRK,FRK_HUMAN,5.62,Kd,Binding constant for FRK kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
182492,1427,920,Solute carrier family 22 member 1,Transporter,O15245,SLC22A1,S22A1_HUMAN,4.77,IC50,Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopy,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
189006,4903,665,Mitogen-activated protein kinase 8,Kinase,P45983,MAPK8,MK08_HUMAN,6.2,Kd,Binding constant for JNK1 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
182860,1992,1872,5-hydroxytryptamine receptor 1D,GPCR,P28565,Htr1d,5HT1D_RAT,4.7,Ki,The binding affinity was measured on 5-hydroxytryptamine 1D receptor using [3H]- serotonin as radioligand.,CHEMBL,=,,,,,,,,,,Rattus norvegicus
33930,313,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.42,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
181701,1952,2827,Soluble guanylate cyclase,Enzyme,O75343|P33402|Q02108|Q02153,GUCY1B2|GUCY1A2|GUCY1A3|GUCY1B3,GCYB2_HUMAN|GCYA2_HUMAN|GCYA3_HUMAN|GCYB1_HUMAN,,,Mechanism of Action; CHEMBL2111348; PROTEIN COMPLEX GROUP,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL730,ACTIVATOR,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
217683,4823,2150,Neuraminidase,Enzyme,B4URF0,,B4URF0_9INFA,10.15,IC50,Inhibition of oseltamivir-resistant Influenza A virus A/WSN/1933(H1N1) recombinant wild type neuraminidase transfected in HEK293 cells using MUNANA as substrate assessed as release of 4-methylumbelliferone preincubated for 10 mins followed by substrate addition measured after 15 mins by fluorometric assay,CHEMBL,=,,,,,,,,,,Influenza A virus (A/WSN/1933(H1N1))
183121,3514,2812,Cyclin-dependent kinase 4/cyclin D1,Kinase,P11802|P24385,CDK4|CCND1,CDK4_HUMAN|CCND1_HUMAN,4.21,IC50,Inhibitory activity against cyclin-dependent kinase 4-cyclin D1,CHEMBL,=,,,,,,,Tchem|Tclin|Tchem|Tclin,,,Homo sapiens
182264,2861,2617,Thymidylate kinase,Kinase,P9WKE1,tmk,KTHY_MYCTU,4.55,Ki,Inhibitory activity against thymidine monophosphate kinase (TMPK) in Mycobacterium tuberculosis,CHEMBL,=,,,,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
164673,312,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,10.18,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
38206,3659,104,5-hydroxytryptamine receptor 6,GPCR,P50406,HTR6,5HT6R_HUMAN,6.106,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
188577,4601,190,Multidrug resistance-associated protein 1,Transporter,P33527,ABCC1,MRP1_HUMAN,5.52,IC50,Inhibition of MRP1,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
27188,2813,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,5.698,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
182291,228,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.53,Ki,Ability to displace [3H]8-OH-DPAT binding to rat hippocampal 5-hydroxytryptamine 1A receptor,CHEMBL,=,,,,,,,,,,Rattus norvegicus
27530,2181,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.456,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
187231,2781,3533,GABA-A receptor; anion channel,Ion channel,O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABRP|GABRD|GABRA1|GABRB1|GABRG2|GABRB3|GABRA5|GABRA3|GABRA2|GABRB2|GABRA4|GABRE|GABRA6|GABRG1|GABRG3|GABRQ,GBRP_HUMAN|GBRD_HUMAN|GBRA1_HUMAN|GBRB1_HUMAN|GBRG2_HUMAN|GBRB3_HUMAN|GBRA5_HUMAN|GBRA3_HUMAN|GBRA2_HUMAN|GBRB2_HUMAN|GBRA4_HUMAN|GBRE_HUMAN|GBRA6_HUMAN|GBRG1_HUMAN|GBRG3_HUMAN|GBRT_HUMAN,4.24,IC50,Displacement of [3H]GABA from gamma-aminobutyric-acid A (GABA-A) receptor,CHEMBL,=,,,,,,,Tclin|Tbio|Tchem|NA,,,Homo sapiens
189029,4903,2210,Serine/threonine-protein kinase LATS1,Kinase,O95835,LATS1,LATS1_HUMAN,6.38,Kd,Binding constant for LATS1 kinase domain,CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
215310,2441,845,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A",Enzyme,O60658,PDE8A,PDE8A_HUMAN,4.0,IC50,,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
184268,1922,2606,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,O35505,CACNA1C,CAC1C_CAVPO,8.59,IC50,Antagonist activity at Cavia porcellus albino (guinea pig) calcium channel assessed as inhibition of KCl-induced ileal longitudinal smooth muscle contraction,CHEMBL,=,,,,,,,,,,Cavia porcellus
188159,4266,1292,Endolysin,Enzyme,P00720,E,ENLYS_BPT4,4.04,Kd,Dissociation constant against T4 lysozyme mutant L99A/M102Q,CHEMBL,=,,,,,,,,,,Enterobacteria phage T4
35174,954,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,9.381,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
187734,4187,776,Tyrosine-protein kinase Fer,Kinase,P16591,FER,FER_HUMAN,6.57,Kd,Binding constant for FER kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
185029,1045,727,Tyrosine-protein kinase CSK,Kinase,P41240,CSK,CSK_HUMAN,5.02,Kd,Binding constant for CSK kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
163828,1202,2794,GABA A receptor alpha-3/beta-2/gamma-3,Ion channel,P34903|P47870|Q99928,GABRA3|GABRB2|GABRG3,GBRA3_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,7.5,Ki,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
185131,2339,2846,Serotonin (5-HT) receptor,GPCR,P08909|P14842|P19327|P28564|P28565|P30940|P30994|P31388|P32305|P35364|P35365|P35563|Q62758|Q9JJ16,Htr2c|Htr2a|Htr1a|Htr1b|Htr1d|Htr1f|Htr2b|Htr6|Htr7|Htr5a|Htr5b|Htr3a|Htr4|Htr3b,5HT2C_RAT|5HT2A_RAT|5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT|5HT2B_RAT|5HT6R_RAT|5HT7R_RAT|5HT5A_RAT|5HT5B_RAT|5HT3A_RAT|5HT4R_RAT|5HT3B_RAT,5.64,IC50,"In vitro inhibitory activity was evaluated against,[3H]spiperone rat frontal cortex (SPFC) serotonin receptor",CHEMBL,=,,,,,,,,,,Rattus norvegicus
187725,4187,839,Tyrosine-protein kinase Fgr,Kinase,P09769,FGR,FGR_HUMAN,6.17,Kd,Binding constant for FGR kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
187657,4178,965,Serine/threonine-protein kinase receptor R3,Kinase,P37023,ACVRL1,ACVL1_HUMAN,6.33,Kd,Binding constant for ACVRL1 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
222751,5509,5017,Prostate-specific antigen,Surface antigen,P07288,KLK3,KLK3_HUMAN,8.33,Kd,Mechanism of Action,DRUG LABEL,=,1.0,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/215833Orig1s000MultidisciplineR.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215833s000lbl.pdf,BINDING AGENT,,Tclin,3397.0,3396.0,Homo sapiens
217893,5231,670,Rho-associated protein kinase 1,Kinase,Q13464,ROCK1,ROCK1_HUMAN,5.11,Kd,Binding affinity to ROCK1,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
36864,2032,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,6.342,Ki,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
222242,5280,916,Epithelial discoidin domain-containing receptor 1,Kinase,Q08345,DDR1,DDR1_HUMAN,8.03,Kd,Binding constant for DDR1 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
187317,1513,2422,14-alpha sterol demethylase,Enzyme,Q96W81,cyp51B,Q96W81_ASPFM,7.51,Kd,Binding affinity to Aspergillus fumigatus AF293 sterol 14-alpha demethylase isoenzyme B expressed in Escherichia coli assessed as tight binding affinity constant,CHEMBL,=,,,,,,,,,,Neosartorya fumigata
35517,1057,1727,Progesterone receptor,Transcription factor,Q690N0,PGR,Q690N0_BOVIN,5.372,Ki,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DRUG MATRIX,=,,,,,,,,,,Bos taurus
3819,2611,194,30S ribosomal protein S9,Ribosomal protein,P0A7X3,rpsI,RS9_ECOLI,,,,WOMBAT-PK,,,,,,,,,,,Escherichia coli (strain K12)
163345,488,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.577,EC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
187768,4187,2458,Serine/threonine-protein kinase TAO2,Kinase,Q9UL54,TAOK2,TAOK2_HUMAN,6.05,Kd,Binding constant for TAOK2 kinase domain,CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
218938,5347,2196,Serine/threonine-protein kinase SIK2,Kinase,Q9H0K1,SIK2,SIK2_HUMAN,7.01,Kd,Binding constant for SIK2 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
219295,2214,413,Retinoic acid receptor RXR-alpha,Nuclear hormone receptor,P19793,RXRA,RXRA_HUMAN,4.88,Kd,Binding affinity to RXRalpha-LBD (unknown origin) measured up to 120 sec by surface plasma resonance method,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
220629,2335,5262,Synaptojanin-2,Enzyme,O15056,SYNJ2,SYNJ2_HUMAN,5.9,IC50,"Inhibition of C-Myc/DDK-tagged human recombinant SYNJ2 expressed in HEK293T cells assessed as reduction in 5'-phosphatase activity incubated for 8 mins using fluorescently-labeled PI(3,4)P2 probe and Tapp1 PH-domain as detector protein by fluorescence polarization competitive assay",CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
219398,4119,2475,Bromodomain-containing protein 4,Unclassified,O60885,BRD4,BRD4_HUMAN,7.44,IC50,Inhibition of BRD4 (unknown origin),CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
217773,5231,605,Serine/threonine-protein kinase pim-1,Kinase,P11309,PIM1,PIM1_HUMAN,6.25,Kd,Binding constant for PIM1 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
164388,969,149,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",Enzyme,Q07343,PDE4B,PDE4B_HUMAN,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
182916,2605,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,8.11,Ki,The compound was evaluated for binding affinity against 5-hydroxytryptamine 1A receptor in rat hippocampal membranes using [3H]8-OH-DPAT as radioligand in the presence of 1 mM of MnCl2,CHEMBL,=,,,,,,,,,,Rattus norvegicus
186731,785,868,Tyrosine-protein kinase FRK,Kinase,P42685,FRK,FRK_HUMAN,9.51,Kd,Binding constant for FRK kinase domain,CHEMBL,=,,,,,INHIBITOR,,Tchem,,,Homo sapiens
182927,1650,346,Aldo-keto reductase family 1 member C2,Enzyme,P52895,AKR1C2,AK1C2_HUMAN,5.06,IC50,"Inhibition of human recombinant N-terminal His6-tagged AKR1C2 expressed in Escherichia coli BL21(DE3) cells using 8-Acetyl-2,3,5,6-tetrahydro-1H,4H-11-oxa-3a-aza-benzo[de]anthracen-10-one as substrate after 1 hr by fluorimetric analysis",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
185913,2359,61,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,5.17,IC50,Inhibition of human NaV1.5 expressed in HEK293 cells assessed as blocking of tefluthrin-induced late sodium currents using -20 mV voltage steps at holding potential of -120 mV by whole cell patch clamp Qpatch method,CHEMBL,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1404,BLOCKER,,Tclin,,,Homo sapiens
183314,1153,2856,Adrenergic receptor alpha-1,GPCR,P25100|P35348|P35368,ADRA1D|ADRA1A|ADRA1B,ADA1D_HUMAN|ADA1A_HUMAN|ADA1B_HUMAN,5.3,Kd,Activity at alpha-1 adrenergic receptor in rabbit aorta rings,CHEMBL,=,,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
215557,1626,378,Melatonin receptor type 1A,GPCR,P48039,MTNR1A,MTR1A_HUMAN,9.538,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
27383,2436,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.678,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
35866,1364,312,Cytochrome P450 1A2,Enzyme,P05177,CYP1A2,CP1A2_HUMAN,5.882,IC50,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
186804,785,2206,Myotonin-protein kinase,Kinase,Q09013,DMPK,DMPK_HUMAN,5.89,Kd,Binding constant for DMPK kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
217154,2168,3940,Peptidyl-prolyl cis-trans isomerase FKBP1A,Enzyme,Q62658,Fkbp1a,FKB1A_RAT,8.22,IC50,Indirect measurement of primary target inhibition via rotamase inhibition,IUPHAR,=,,,,,INHIBITOR,,,,,Rattus norvegicus
163743,1602,2732,GABA-A receptor alpha-2/beta-3/gamma-2,Ion channel,P18507|P28472|P47869,GABRG2|GABRB3|GABRA2,GBRG2_HUMAN|GBRB3_HUMAN|GBRA2_HUMAN,,,,WOMBAT-PK,,,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
222157,5202,2218,cAMP-dependent protein kinase catalytic subunit alpha,Kinase,P17612,PRKACA,KAPCA_HUMAN,5.44,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
164857,2557,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
35651,1200,113,Muscarinic acetylcholine receptor M1,GPCR,P11229,CHRM1,ACM1_HUMAN,6.151,Ki,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
36839,2028,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.837,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
219802,2144,4541,E3 ubiquitin-protein ligase XIAP,Unclassified,P98170,XIAP,XIAP_HUMAN,4.1,IC50,Inhibition of human IAP expressed in COS7 cells using CDP-star as substrate preincubated for 5 to 10 mins followed by substrate addition measured after 20 mins by luminescence-based assay,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
183958,1207,2079,Solute carrier family 22 member 20,Transporter,Q80UJ1,Slc22a20,S22AK_MOUSE,4.0,Ki,Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr,CHEMBL,=,,,,,,,,,,Mus musculus
186183,1282,574,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",Kinase,P15735,PHKG2,PHKG2_HUMAN,5.57,Kd,Binding constant for PHKG2 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
196881,852,80,Gamma-aminobutyric acid receptor subunit alpha-5,Ion channel,P31644,GABRA5,GBRA5_HUMAN,7.64,Kd,Binding affinity to GABAA alpha-5-beta-2-gamma-2 receptor,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
183735,2036,2891,Cyclooxygenase,Enzyme,P23219|P35354,PTGS1|PTGS2,PGH1_HUMAN|PGH2_HUMAN,,,Mechanism of Action; CHEMBL2094253; PROTEIN FAMILY,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1228,INHIBITOR,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
183573,701,1842,Sodium-dependent serotonin transporter,Transporter,Q60857,Slc6a4,SC6A4_MOUSE,7.15,IC50,Inhibition of 5-HT transporter in NMRI albino mouse brain assessed as [3H]5-HT accumulation in hypothalamus after 5 mins,CHEMBL,=,,,,,,,,,,Mus musculus
189766,1757,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,9.68,Ki,Displacement of [3H]N-methylscopolamine from human muscarinic M5 receptor expressed in CHO cells after 120 mins by scintillation counting,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
214994,2152,139,Sodium channel protein type 3 subunit alpha,Ion channel,Q9NY46,SCN3A,SCN3A_HUMAN,,,Mechanism of Action,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16,BLOCKER,,Tclin,,,Homo sapiens
38025,2855,816,Mitogen-activated protein kinase 3,Kinase,P27361,MAPK3,MK03_HUMAN,5.359,IC50,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
217762,5231,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,6.55,Kd,Binding constant for LCK kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
37988,2777,621,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,5.395,IC50,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
27299,2558,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,5.41,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
220474,1364,5158,N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D,Unclassified,Q6IQ20,NAPEPLD,NAPEP_HUMAN,5.01,IC50,,IUPHAR,=,,,,,INHIBITOR,,Tbio,,,Homo sapiens
187289,39,1898,"Sucrase-isomaltase, intestinal",Enzyme,P23739,Si,SUIS_RAT,6.4,IC50,Inhibition of rat intestinal sucrase using sucrose as substrate assessed as D-glucose release from substrate preincubated for 15 mins measured after 60 mins,CHEMBL,=,,,,,,,,,,Rattus norvegicus
183127,3514,3574,D-alanylalanine synthetase,Enzyme,P07862,ddlB,DDLB_ECOLI,4.7,IC50,Competitive inhibition of Escherichia coli DdlB using ATP as substrate,CHEMBL,=,,,,,,,,,,Escherichia coli (strain K12)
224161,5728,746,Cytoplasmic tyrosine-protein kinase BMX,Kinase,P51813,BMX,BMX_HUMAN,6.26,Ki,Inhibition of full length recombinant human His-tagged cytoplasmic BMX expressed in baculovirus expression system by KT236 probe based TR-FRET assay,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
219375,4124,2475,Bromodomain-containing protein 4,Unclassified,O60885,BRD4,BRD4_HUMAN,8.0,IC50,Inhibition of BRD4 (unknown origin),CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
187978,4209,158,D(4) dopamine receptor,GPCR,P21917,DRD4,DRD4_HUMAN,5.08,Ki,Displacement of [3H]-YM-09151-2 (0.06 nM) from human Dopamine receptor D4 expressed in CHO cells,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
219720,228,4542,E3 ubiquitin-protein ligase Mdm2,Nuclear other,Q00987,MDM2,MDM2_HUMAN,6.71,IC50,Inhibition of biotin-labelled D-p53 binding to D-MDM2 (25 to 109 residues) (unknown origin) by FAM labeled P4 peptide based fluorescence polarization assay,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
219231,835,1858,Alpha-1A adrenergic receptor,GPCR,P18130,ADRA1A,ADA1A_BOVIN,6.42,EC50,Agonist activity at bovine recombinant alpha-1A receptor expressed in HEK293 cells coexpressing Gag-pol assessed as increase in intracellular calcium measured after 60 mins by fluo-4 dye based FLIPR assay,CHEMBL,=,,,,,,,,,,Bos taurus
219926,5306,708,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,8.96,IC50,,IUPHAR,=,,,,,INHIBITOR,,Tclin,,,Homo sapiens
221961,5209,5965,Mitotic checkpoint serine/threonine-protein kinase BUB1,Kinase,O43683,BUB1,BUB1_HUMAN,5.54,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
187244,3535,2064,Serum albumin,Secreted,P02769,ALB,ALBU_BOVIN,4.38,IC50,Inhibition of glycation of bovine serum albumin assessed as advanced glycated end product measured after 7 days by spectrofluorimeter in presence of glucose anhydrous,CHEMBL,=,,,,,,,,,,Bos taurus
221801,5259,793,Serine/threonine-protein kinase 16,Kinase,O75716,STK16,STK16_HUMAN,6.3,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
186505,3533,573,Ribosomal protein S6 kinase alpha-3,Kinase,P51812,RPS6KA3,KS6A3_HUMAN,5.66,Kd,Average Binding Constant for RPS6KA3 (Kin.Dom. 1); NA=Not Active at 10 uM,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
215804,2863,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,5.027,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
182088,1574,2779,Glutamate NMDA receptor,Ion channel,P35439|Q00959|Q00960|Q00961|Q62645|Q8VHN2|Q9R1M7,Grin1|Grin2a|Grin2b|Grin2c|Grin2d|Grin3b|Grin3a,NMDZ1_RAT|NMDE1_RAT|NMDE2_RAT|NMDE3_RAT|NMDE4_RAT|NMD3B_RAT|NMD3A_RAT,5.92,IC50,Binding affinity against PCP binding site associated with N-methyl-D-aspartate glutamate receptor from rat synaptic plasma membrane(SPM) determined using [3H]TCP as radioligand.,CHEMBL,=,,,,,,,,,,Rattus norvegicus
164334,2796,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,7.9,Ki,,WOMBAT-PK,=,1.0,KEGG DRUG,,http://www.kegg.jp/entry/D01333,ANTAGONIST,,Tclin,,,Homo sapiens
223100,1358,6362,"Spike glycoprotein, S glycoprotein",Unclassified,P59594,S,SPIKE_SARS,6.3,Kd,,IUPHAR,=,,,,,,,,,,Severe acute respiratory syndrome coronavirus
215162,5110,3499,Beta-galactosidase,Enzyme,P16278,GLB1,BGAL_HUMAN,4.05,IC50,,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
38446,4507,127,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,9.135,Ki,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),DRUG MATRIX,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200845,AGONIST,,Tclin,,,Homo sapiens
163991,2784,366,Trace amine-associated receptor 1,GPCR,Q96RJ0,TAAR1,TAAR1_HUMAN,7.16,EC50,,WOMBAT-PK,=,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/21073468,AGONIST,,Tclin,,377.0,Homo sapiens
34700,779,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,5.087,Ki,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
186950,597,2514,Solute carrier family 22 member 3,Transporter,O75751,SLC22A3,S22A3_HUMAN,6.39,IC50,Inhibition of human OCT3-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
184723,1353,1888,Protease,Enzyme,Q4U254,protease,Q4U254_9ENTO,7.0,Ki,The compound was tested for its affinity against HIV-2 protease,CHEMBL,=,,,,,,,,,,Human rhinovirus sp
186229,242,97,Multidrug resistance protein 1,Transporter,P08183,ABCB1,MDR1_HUMAN,6.11,IC50,Inhibition of human ABCB1-mediated rhodamine 123 efflux in mouse L5178 cells expressing human MDR1 after 20 mins by FACS analysis,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
216939,5226,320,Synaptic vesicular amine transporter,Transporter,Q05940,SLC18A2,VMAT2_HUMAN,,,,UNKNOWN,,1.0,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208082s000lbl.pdf,INHIBITOR,,Tclin,,657.0,Homo sapiens
181505,1809,2600,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,O89085,PDE4A,PDE4A_CAVPO,5.33,Ki,Inhibition of Cavia porcellus (guinea pig) PDE3 isolated from heart using [3H]cAMP as substrate by two-step method,CHEMBL,=,,,,,,,,,,Cavia porcellus
183894,1752,2429,Pleiotropic ABC efflux transporter of multiple drugs,Transporter,P33302,PDR5,PDR5_YEAST,5.02,IC50,Inhibition of Pdr5p-mediated rhodamine 6G transport in Saccharomyces cerevisiae MKPDR5h plasma membrane by spectrofluorometric assay,CHEMBL,=,,,,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
218762,5347,2367,Megakaryocyte-associated tyrosine-protein kinase,Kinase,P42679,MATK,MATK_HUMAN,5.77,Kd,Binding constant for CTK kinase domain,CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
188846,4881,2630,Orexin receptor type 1,GPCR,P58307,Hcrtr1,OX1R_MOUSE,8.77,Ki,Antagonist activity at mouse OX1 receptor expressed in CHO cells assessed as inhibition of orexin A-induced Ca2+ accumulation after 1 hr by Fluo-4-AM staining-based FLIPR assay,CHEMBL,=,,,,,,,,,,Mus musculus
222379,4185,2024,Protein-tyrosine kinase 6,Kinase,Q13882,PTK6,PTK6_HUMAN,5.85,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
208824,133,2760,GABA A receptor alpha-2/beta-2/gamma-2,Ion channel,P18507|P47869|P47870,GABRG2|GABRA2|GABRB2,GBRG2_HUMAN|GBRA2_HUMAN|GBRB2_HUMAN,5.7,EC50,Effective concentration against GABA-evoked chloride currents mediated by human Gamma-aminobutyric acid GABA-A receptor alpha2-beta2-gamma2L expressed in Xenopus oocytes,CHEMBL,=,,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
163556,176,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.22,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
37196,2286,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.382,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
221729,5419,698,Mitogen-activated protein kinase 10,Kinase,P53779,MAPK10,MK10_HUMAN,5.67,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
187078,1932,533,Tyrosine-protein kinase Lck,Kinase,P06239,LCK,LCK_HUMAN,7.33,Kd,Binding constant for LCK kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
185893,784,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,8.1,Ki,GRAC: human M4 antagonist,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
35451,1042,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.201,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
224061,1728,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.68,Ki,Displacement of [3H]-N-methylspiperone from human dopamine D3 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
185249,2544,674,Tyrosine-protein kinase HCK,Kinase,P08631,HCK,HCK_HUMAN,6.06,Kd,Binding constant for HCK kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
183586,1148,505,Extracellular calcium-sensing receptor,GPCR,P41180,CASR,CASR_HUMAN,6.0,EC50,Positive allosteric modulation of human CaSR transfected in CHO cells after 5 hrs by luciferase reporter gene assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
182754,3631,1765,Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI,Enzyme,Q6GI75,fabI,FABI_STAAR,7.15,IC50,Inhibitory activity against Enoyl-ACP reductase FabI in Staphylococcus aureus,CHEMBL,=,,,,,,,,,,Staphylococcus aureus (strain MRSA252)
217002,642,3945,Voltage-dependent N-type calcium channel subunit alpha-1B,Ion channel,Q02294,Cacna1b,CAC1B_RAT,6.7,IC50,,IUPHAR,=,,,,,BLOCKER,,,,,Rattus norvegicus
220465,5460,249,Delta-type opioid receptor,GPCR,P41143,OPRD1,OPRD_HUMAN,8.59,Ki,,DRUG LABEL,=,,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/213378s000lbl.pdf,,PARTIAL AGONIST,,Tclin,3224.0,,Homo sapiens
216931,5218,2322,Cyclin-dependent kinase 4,Kinase,P11802,CDK4,CDK4_HUMAN,8.0,IC50,,SCIENTIFIC LITERATURE,=,1.0,DRUG LABEL,https://pubmed.ncbi.nlm.nih.gov/25941111,http://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209092s000lbl.pdf,INHIBITOR,,Tclin,651.0,650.0,Homo sapiens
181825,1741,2285,Alpha carbonic anhydrase,Enzyme,B5SU02,CA,B5SU02_9CNID,7.67,Ki,Inhibition of cloned Stylophora pistillata alpha-CA expressed in human HEK293 cells by stopped-flow CO2 assay,CHEMBL,=,,,,,,,,,,Stylophora pistillata
185753,1973,2494,Multidrug and toxin extrusion protein 1,Transporter,Q96FL8,SLC47A1,S47A1_HUMAN,4.46,IC50,Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
217784,5231,915,Calcium/calmodulin-dependent protein kinase type 1G,Kinase,Q96NX5,CAMK1G,KCC1G_HUMAN,5.75,Kd,Binding constant for CAMK1G kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
217675,1893,2581,Protease,Enzyme,Q9YQ12,protease,Q9YQ12_9HIV1,10.15,Ki,Inhibition of wild-type HIV1 BH10 protease expressed in Escherichia coli by spectrophotometric assay,CHEMBL,=,,,,,,,,,,Human immunodeficiency virus 1
162927,1043,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,,,,WOMBAT-PK,,,,,,AGONIST,,Tclin,,,Homo sapiens
215271,3601,1026,Gamma-butyrobetaine dioxygenase,Enzyme,O75936,BBOX1,BODG_HUMAN,5.24,IC50,,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
222586,5306,747,Serine/threonine-protein kinase Nek2,Kinase,P51955,NEK2,NEK2_HUMAN,6.61,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
187721,4187,2264,Ephrin type-A receptor 1,Kinase,P21709,EPHA1,EPHA1_HUMAN,6.85,Kd,Binding constant for EPHA1 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
162515,1797,269,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,O95180,CACNA1H,CAC1H_HUMAN,6.602,IC50,,WOMBAT-PK,=,1.0,SCIENTIFIC LITERATURE,,https://pubmed.ncbi.nlm.nih.gov/18974361,BLOCKER,,Tclin,,239.0,Homo sapiens
188895,4903,2068,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,6.51,Kd,Binding constant for BTK kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
182568,2387,1964,Farnesyl pyrophosphate synthase,Enzyme,Q0GKD7,,Q0GKD7_LEIDO,7.77,Ki,Binding affinity towards Farnesyl diphosphate synthase from leishmania major,CHEMBL,=,,,,,,,,,,Leishmania donovani
224055,4174,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,5.82,IC50,Inhibition of human ABCG2 expressed in dog MDCK-II-BCRP cells mediated pheophorbide A efflux by flow cytometry,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
186075,4118,847,ALK tyrosine kinase receptor,Kinase,Q9UM73,ALK,ALK_HUMAN,5.66,Kd,Binding constant for ALK kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
182380,1057,2013,Estrogen receptor,Transcription factor,P19785,Esr1,ESR1_MOUSE,8.66,IC50,Inhibition of [3H]17-beta-estradiol binding to mouse ER alpha expressed in Escherichia coli,CHEMBL,=,,,,,,,,,,Mus musculus
35984,1529,1707,Aldose reductase,Enzyme,P07943,Akr1b1,ALDR_RAT,5.214,IC50,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
215580,1707,116,Muscarinic acetylcholine receptor M4,GPCR,P08173,CHRM4,ACM4_HUMAN,7.955,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
180632,4957,546,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,,,,UNKNOWN,,1.0,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125409s104lbl.pdf,ANTIBODY BINDING,,Tclin,,217.0,Homo sapiens
217187,2620,3991,Adenosine receptor A2b,GPCR,Q60614,Adora2b,AA2BR_MOUSE,5.25,Ki,,IUPHAR,=,,,,,ANTAGONIST,,,,,Mus musculus
34244,654,74,Mu-type opioid receptor,GPCR,P35372,OPRM1,OPRM_HUMAN,6.035,Ki,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
223763,4749,294,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,6.39,Ki,,IUPHAR,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
37850,2637,170,Alpha-1D adrenergic receptor,GPCR,P25100,ADRA1D,ADA1D_HUMAN,8.686,Ki,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
219300,4716,669,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,8.03,IC50,"Inhibition of recombinant FGFR3 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
183797,1419,3455,Glutamate [NMDA] receptor subunit epsilon 2,Ion channel,Q00960,Grin2b,NMDE2_RAT,7.96,Ki,Displacement of [3H]ifenprodil from rat brain membrane NR2B receptor,CHEMBL,=,,,,,,,,,,Rattus norvegicus
219169,621,397,Potassium channel subfamily K member 2,Ion channel,O95069,KCNK2,KCNK2_HUMAN,5.57,IC50,Inhibition of of human TREK1 expressed in whole COS cells assessed as reduction in channel currents,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
188193,4310,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,6.48,Ki,Inhibition of human recombinant CA2 by stopped flow CO2 hydrase assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
163599,671,145,Cytochrome P450 2D6,Enzyme,P10635,CYP2D6,CP2D6_HUMAN,5.699,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
216378,3659,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,6.9,IC50,,CHEMBL,=,,,,,,,,,,Rattus norvegicus
36108,1588,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,7.174,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
217642,5229,4145,Purine nucleoside phosphorylase,Enzyme,P55859,PNP,PNPH_BOVIN,10.64,Ki,Inhibitory activity of compound against bovine purine nucleoside phosphorylase (PNP),CHEMBL,=,,,,,,,,,,Bos taurus
182469,1276,395,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,5.66,IC50,Displacement of [3H]BRL49653 from Homo sapiens (human) PPARgamma receptor by scintillation proximity assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
218355,5337,4256,Interleukin-23 subunit alpha,Cytokine,Q9NPF7,IL23A,IL23A_HUMAN,11.0,Kd,selectively binds to the p19 subunit of human IL-23,SCIENTIFIC LITERATURE,=,1.0,DRUG LABEL,https://pubmed.ncbi.nlm.nih.gov/25905918,https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/761105s000lbl.pdf,INHIBITOR,,Tclin,2693.0,2692.0,Homo sapiens
180875,738,399,"Carbonic anhydrase 5B, mitochondrial",Enzyme,Q9Y2D0,CA5B,CAH5B_HUMAN,5.28,Ki,Inhibition of human carbonic anhydrase 5B by stopped flow CO2 hydration assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
26310,228,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.9,Ki,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
215715,1971,83,D(2) dopamine receptor,GPCR,P14416,DRD2,DRD2_HUMAN,5.59,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
36192,1659,470,Cytochrome P450 2C19,Enzyme,P33261,CYP2C19,CP2CJ_HUMAN,5.699,IC50,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
164722,1353,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,7.9,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
189171,5006,327,P2Y purinoceptor 12,GPCR,Q9H244,P2RY12,P2Y12_HUMAN,8.627,IC50,cAMP accumulation in HORK3-expressing cells,SCIENTIFIC LITERATURE,=,1.0,DRUG LABEL,https://pubmed.ncbi.nlm.nih.gov/11502873,http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204958lbl.pdf,ANTAGONIST,,Tclin,364.0,365.0,Homo sapiens
204306,2870,77,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,P47869,GABRA2,GBRA2_HUMAN,6.39,Ki,Displacement of [3H]Ro-151788 from benzodiazepine binding site of GABAA alpha-2-beta-2-gamma-2 receptor expressed in HEK293T cells,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
223528,5353,746,Cytoplasmic tyrosine-protein kinase BMX,Kinase,P51813,BMX,BMX_HUMAN,8.27,IC50,Inhibition of full-length N-terminal GST-tagged BMX (1 to 675 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
183060,2034,1769,Kappa-type opioid receptor,GPCR,P41144,OPRK1,OPRK_CAVPO,7.24,Ki,Displacement of [3H]U69593 from kappa opioid receptor in guinea pig cerebellum homogenate by scintillation counting,CHEMBL,=,,,,,,,,,,Cavia porcellus
164383,816,155,Gamma-aminobutyric acid receptor subunit rho-2,Ion channel,P28476,GABRR2,GBRR2_HUMAN,,,,WOMBAT-PK,,,,,,,,Tbio,,,Homo sapiens
33714,176,988,Androgen receptor,Transcription factor,P15207,Ar,ANDR_RAT,4.55,Ki,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
163175,2546,56,Prostaglandin G/H synthase 2,Enzyme,P35354,PTGS2,PGH2_HUMAN,5.06,IC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL253765,INHIBITOR,,Tclin,,,Homo sapiens
185414,2544,714,Protein kinase C alpha type,Kinase,P17252,PRKCA,KPCA_HUMAN,5.22,Kd,Average Binding Constant for PRKACA; NA=Not Active at 10 uM,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
217262,4508,106,Alpha-1A adrenergic receptor,GPCR,P35348,ADRA1A,ADA1A_HUMAN,5.0,Ki,,IUPHAR,=,,,,,AGONIST,,Tclin,,,Homo sapiens
95743,1795,2525,Interleukin-1 receptor type 1,Membrane receptor,P14778,IL1R1,IL1R1_HUMAN,6.52,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
220897,4143,5548,Protease,Unclassified,Q9YQ30,HIV-1 protease,Q9YQ30_9PLVG,10.82,Ki,Inhibition of HIV1 recombinant protease L10I/I15V/E35D/N37S/R41K/I62V/L63P/A71V/G73S/L90M mutant expressed in Escherichia coli by spectrophotometric assay,CHEMBL,=,,,,,,,,,,Human immunodeficiency virus
164201,2172,219,Calmodulin,Cytosolic other,P0DP23|P0DP24|P0DP25,CALM1|CALM2|CALM3,CALM1_HUMAN|CALM2_HUMAN|CALM3_HUMAN,5.222,IC50,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin,,,Homo sapiens
187652,4178,544,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,5.92,Kd,Binding constant for CSF1R kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
181771,2492,3553,Beta-lactamase 1,Enzyme,P00809,blaY,BLAC_BACCE,4.6,IC50,Inhibition of Beta-lactamase of Bacillus cereus (class A enzyme) without pre-incubation,CHEMBL,=,,,,,,,,,,Bacillus cereus
221832,5280,898,Ephrin type-A receptor 7,Kinase,Q15375,EPHA7,EPHA7_HUMAN,7.41,Kd,Binding constant for EPHA7 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
181417,835,2854,Adrenergic receptor alpha-1,GPCR,P15823|P23944|P43140,Adra1b|Adra1d|Adra1a,ADA1B_RAT|ADA1D_RAT|ADA1A_RAT,8.3,Ki,Tested for Binding affinity towards alpha-1 adrenergic receptor,CHEMBL,=,,,,,,,,,,Rattus norvegicus
182616,1640,98,Sodium-dependent serotonin transporter,Transporter,P31645,SLC6A4,SC6A4_HUMAN,7.3,Ki,Displacement of [125I]- RTI-55 from Serotonin transporter expressed in HEK cells,CHEMBL,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL781,INHIBITOR,,Tclin,,,Homo sapiens
33981,333,1721,Membrane-associated progesterone receptor component 1,Membrane receptor,P70580,Pgrmc1,PGRC1_RAT,6.951,Ki,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
189037,4903,2358,Mitogen-activated protein kinase kinase kinase 19,Kinase,Q56UN5,MAP3K19,M3K19_HUMAN,8.28,Kd,Binding constant for YSK4 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
215700,1150,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,5.726,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
218135,5280,715,Tyrosine-protein kinase SYK,Kinase,P43405,SYK,KSYK_HUMAN,7.387,IC50,,SCIENTIFIC LITERATURE,=,1.0,DRUG LABEL,https://doi.org/10.1124/jpet.106.109058,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209299lbl.pdf,INHIBITOR,1.0,Tclin,2311.0,2310.0,Homo sapiens
162394,138,493,Prostaglandin E2 receptor EP2 subtype,GPCR,P43116,PTGER2,PE2R2_HUMAN,8.0,EC50,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL495,AGONIST,,Tclin,,,Homo sapiens
187014,1328,859,Induced myeloid leukemia cell differentiation protein Mcl-1,Cytosolic other,Q07820,MCL1,MCL1_HUMAN,6.74,Ki,Displacement of FAM-Bid from human Mcl1 by FP assay,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
218868,5347,2142,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Kinase,P42336,PIK3CA,PK3CA_HUMAN,5.41,Kd,Binding constant for PIK3CA(H1047L) kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
223569,4183,2534,Cytochrome P450 1B1,Enzyme,Q16678,CYP1B1,CP1B1_HUMAN,4.23,IC50,Inhibition of human CYP1B1 using 7-ethyl-O-resorufin as substrate incubated for 30 mins in presence of NADPH by EROD assay,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
215613,1890,103,5-hydroxytryptamine receptor 2C,GPCR,P28335,HTR2C,5HT2C_HUMAN,7.143,Ki,,PDSP,,,,,,,,Tclin,,,Homo sapiens
185645,522,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,6.46,IC50,Inhibitory concentration against IKr potassium channel,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
223764,5728,679,Tyrosine-protein kinase JAK1,Kinase,P23458,JAK1,JAK1_HUMAN,5.79,IC50,At 1 mM ATP.,IUPHAR,=,,,,,INHIBITOR,,Tclin,,,Homo sapiens
217003,645,3593,Histamine H2 receptor,GPCR,P25102,Hrh2,HRH2_RAT,5.9,Ki,,IUPHAR,=,,,,,ANTAGONIST,,,,,Rattus norvegicus
187342,3482,202,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,,,Mechanism of Action; CHEMBL206; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201477,AGONIST,,Tclin,,,Homo sapiens
217752,5231,883,Cyclin-G-associated kinase,Kinase,O14976,GAK,GAK_HUMAN,6.42,Kd,Binding constant for GAK kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
222574,4938,2220,Mitogen-activated protein kinase kinase kinase kinase 3,Kinase,Q8IVH8,MAP4K3,M4K3_HUMAN,5.49,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
188964,4903,914,Calcium/calmodulin-dependent protein kinase kinase 1,Kinase,Q8N5S9,CAMKK1,KKCC1_HUMAN,6.2,Kd,Binding constant for CAMKK1 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
163463,722,91,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,5.2,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
217288,5046,1729,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,P36507,MAP2K2,MP2K2_HUMAN,6.7,IC50,,IUPHAR,=,,,,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
219353,3927,183,Mineralocorticoid receptor,Nuclear hormone receptor,P08235,NR3C2,MCR_HUMAN,6.44,IC50,Binding affinity to MR (unknown origin),CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
224130,258,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,6.64,IC50,Inhibition of ABCG2 (unknown origin) expressed in human HEK293 cells membrane vesicles assessed inhibition of BCRP- mediated transport of 3[H]-E1S for 1 to 5 mins using [3H]-estrone sulfate as substrate by rapid filtration technique,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
217640,4945,1848,Gastrin/cholecystokinin type B receptor,GPCR,P56481,Cckbr,GASR_MOUSE,9.52,IC50,Evaluated for inhibition of cholecystokinin type B receptor by displacing [125I]-Bolton hunter CCK-8 radioligand in the mouse cerebral cortex,CHEMBL,=,,,,,,,,,,Mus musculus
180774,2153,882,Beta-secretase 1,Enzyme,P56817,BACE1,BACE1_HUMAN,4.44,IC50,Inhibition of human recombinant BACE1 after 60 mins by FRET assay,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
37337,2350,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.102,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
166023,1942,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,4.638,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
164436,3584,132,Alpha-2C adrenergic receptor,GPCR,P18825,ADRA2C,ADA2C_HUMAN,6.88,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
183167,3514,605,Serine/threonine-protein kinase pim-1,Kinase,P11309,PIM1,PIM1_HUMAN,7.6,Kd,Binding affinity to non phosphorylated PIM1,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
183101,3514,88,Urokinase-type plasminogen activator,Enzyme,P00749,PLAU,UROK_HUMAN,4.92,IC50,Inhibition of urokinase amidolytic activity (unknown origin),CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
188929,4903,2181,Casein kinase II subunit alpha',Kinase,P19784,CSNK2A2,CSK22_HUMAN,6.05,Kd,Binding constant for CSNK2A2 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
185223,2544,871,Dual specificity protein kinase CLK2,Kinase,P49760,CLK2,CLK2_HUMAN,7.7,Kd,Binding constant for CLK2 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
216464,1310,1204,Glutamate receptor 2,Ion channel,P19491,Gria2,GRIA2_RAT,6.55,Ki,,CHEMBL,=,,,,,,,,,,Rattus norvegicus
216983,343,3975,Prostacyclin receptor,GPCR,P43252,Ptgir,PI2R_MOUSE,7.8,Ki,,IUPHAR,=,,,,,AGONIST,,,,,Mus musculus
187127,119,779,Renin,Enzyme,Q6DLS0,REN,RENI_MACFA,8.1,IC50,Inhibition of cynomolgus monkey plasma renin activity after 60 mins by competitive RIA,CHEMBL,=,,,,,,,,,,Macaca fascicularis
142097,4898,417,Substance-P receptor,GPCR,P25103,TACR1,NK1R_HUMAN,9.022,Ki,displacement of [3H]-labelled substance P from cloned human receptor expressed in CHO cells,SCIENTIFIC LITERATURE,=,1.0,SCIENTIFIC LITERATURE,https://pubmed.ncbi.nlm.nih.gov/16332435,https://pubmed.ncbi.nlm.nih.gov/16332435,ANTAGONIST,,Tclin,47.0,47.0,Homo sapiens
221737,464,5998,Vitamin D3 receptor,Nuclear hormone receptor,P48281,Vdr,VDR_MOUSE,6.22,EC50,Activation of VDR in mouse ASZ001 cells assessed as change in Cyp24A1 mRNA expression after 48 hrs by q-PCR analysis,CHEMBL,=,,,,,,,,,,Mus musculus
183540,2279,1145,"Fatty acid-binding protein, liver",Unclassified,P02692,Fabp1,FABPL_RAT,7.57,Ki,Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay,CHEMBL,=,,,,,,,,,,Rattus norvegicus
33692,176,117,Muscarinic acetylcholine receptor M5,GPCR,P08912,CHRM5,ACM5_HUMAN,5.968,Ki,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
216003,3535,3818,Neuraminidase,Enzyme,P03469,,NRAM_I77AB,4.02,IC50,,CHEMBL,=,,,,,,,,,,Influenza A virus (strain A/USSR/90/1977 H1N1)
181431,2621,2751,Tubulin,Structural,F1L005|F1L4P8|F1L5G6|F1L7U3|F1L7Y0|F1L8A5|F1LCS0,,F1L005_ASCSU|F1L4P8_ASCSU|F1L5G6_ASCSU|F1L7U3_ASCSU|F1L7Y0_ASCSU|F1L8A5_ASCSU|F1LCS0_ASCSU,,,Mechanism of Action; CHEMBL2364705; PROTEIN COMPLEX GROUP,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL625,INHIBITOR,,,,,Ascaris suum
188594,4618,2076,Prostaglandin G/H synthase 1,Enzyme,O62664,PTGS1,PGH1_BOVIN,4.03,IC50,Inhibition of bovine COX1-mediated prostaglandin biosynthesis using [1-14C]arachidonic acid,CHEMBL,=,,,,,,,,,,Bos taurus
218461,5313,4388,transthyretin (TTR) mRNA,RNA,P02766,TTR,TTHY_HUMAN,,,Mechanism of Action,UNKNOWN,,1.0,DRUG LABEL,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210922s000lbl.pdf,ANTISENSE INHIBITOR,,Tclin,,2570.0,Homo sapiens
216594,395,172,Alpha-1B adrenergic receptor,GPCR,P35368,ADRA1B,ADA1B_HUMAN,5.27,Ki,,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
26083,1613,110,Histamine H1 receptor,GPCR,P35367,HRH1,HRH1_HUMAN,8.2,Ki,,IUPHAR,=,,,,,ANTAGONIST,,Tclin,,,Homo sapiens
218881,5347,2261,Tyrosine-protein kinase Srms,Kinase,Q9H3Y6,SRMS,SRMS_HUMAN,5.3,Kd,Binding constant for SRMS kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
216189,829,1834,Glucocorticoid receptor,Transcription factor,P06536,Nr3c1,GCR_RAT,7.66,IC50,,CHEMBL,=,,,,,,,,,,Rattus norvegicus
164272,1634,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,,,,WOMBAT-PK,,,,,,,,Tchem,,,Homo sapiens
25448,158,952,Acid-sensing ion channel 2,Ion channel,Q16515,ASIC2,ASIC2_HUMAN,4.6,IC50,,IUPHAR,=,,,,,BLOCKER,,Tbio,,,Homo sapiens
183083,2579,245,5-hydroxytryptamine receptor 4,GPCR,Q13639,HTR4,5HT4R_HUMAN,8.4,Ki,Binding affinity at 5HT4 receptor,CHEMBL,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL76370,PARTIAL AGONIST,,Tclin,,,Homo sapiens
35653,1200,115,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.504,Ki,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
163870,398,1781,Dihydrofolate reductase,Enzyme,P0ABQ4,folA,DYR_ECOLI,8.18,Ki,,WOMBAT-PK,=,,,,,,,,,,Escherichia coli (strain K12)
218179,5302,894,Activated CDC42 kinase 1,Kinase,Q07912,TNK2,ACK1_HUMAN,7.77,IC50,,SCIENTIFIC LITERATURE,=,1.0,DRUG LABEL,https://pubmed.ncbi.nlm.nih.gov/25733882,https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210868s000lbl.pdf,INHIBITOR,,Tclin,2538.0,2535.0,Homo sapiens
182962,972,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,8.22,Ki,Inhibition of human NET,CHEMBL,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1175,INHIBITOR,,Tclin,,,Homo sapiens
183549,2279,2014,C-8 sterol isomerase,Enzyme,P32352,ERG2,ERG2_YEAST,5.35,Ki,Affinity for ERG2 of Saccharomyces cerevisiae using [3H]ifenprodil or (+)-[3H]pentazocine radioligand,CHEMBL,=,,,,,,,,,,Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
219106,4006,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,9.0,EC50,Agonist activity at recombinant human 5HT2B receptor expressed in Flp-In-293 cells assessed as calcium flux by FLIPR assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
186625,2351,102,5-hydroxytryptamine receptor 2B,GPCR,P41595,HTR2B,5HT2B_HUMAN,7.16,Ki,Displacement of [3H]LSD from human cloned 5HT2B receptor expressed in CHO cells by liquid scintillation counting,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
216412,673,1749,5-hydroxytryptamine receptor 1A,GPCR,P19327,Htr1a,5HT1A_RAT,5.58,IC50,,CHEMBL,=,,,,,,,,,,Rattus norvegicus
182995,594,1793,Acetylcholinesterase,Enzyme,O42275,ache,ACES_ELEEL,4.3,Ki,Inhibition of Electrophorus electricus (electric eel) acetylcholinesterase (AChE) assessed as inhibition of ATCh hydrolysis by Ellman method,CHEMBL,=,,,,,,,,,,Electrophorus electricus
182246,3486,3558,Beta-2 adrenergic receptor,GPCR,P18762,Adrb2,ADRB2_MOUSE,4.87,Ki,Ki value was determined by accumulation of c-AMP in S-49 mouse lymphoma cells (Beta2).,CHEMBL,=,,,,,,,,,,Mus musculus
163623,723,94,Potassium voltage-gated channel subfamily H member 2,Ion channel,Q12809,KCNH2,KCNH2_HUMAN,5.14,IC50,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
216640,888,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,8.3,IC50,,CHEMBL,=,,,,,,,,,,Rattus norvegicus
163779,997,2731,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,P14867|P18507|P47870,GABRA1|GABRG2|GABRB2,GBRA1_HUMAN|GBRG2_HUMAN|GBRB2_HUMAN,7.301,IC50,,WOMBAT-PK,=,,,,,,,Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
183433,3493,3586,Acrosin,Enzyme,P08001,ACR,ACRO_PIG,5.46,Ki,Reversible competitive inhibition of boar spermatozoa acrosin using BzArgOEt as substrate by Dixon plot analysis,CHEMBL,=,,,,,,,,,,Sus scrofa
187569,4178,382,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,8.05,Kd,Binding constant for ABL1(Y253F)-phosphorylated kinase domain,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
186358,2459,2310,Tyrosine-protein kinase ABL1,Kinase,P00520,Abl1,ABL1_MOUSE,6.65,IC50,Inhibition of mouse recombinant N-terminal His6-tagged Abl by radiometric kinase assay,CHEMBL,=,,,,,,,,,,Mus musculus
37937,2728,369,Caspase-1,Enzyme,P29466,CASP1,CASP1_HUMAN,5.436,IC50,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",DRUG MATRIX,=,,,,,,,Tchem,,,Homo sapiens
218059,2977,4129,"1,3-beta-D-glucan synthase catalytic subunit",Unclassified,O13383,CaFKS1,O13383_CANAX,9.62,IC50,"Inhibition of wild type Candida albicans MY1055 1,3-beta-D-glucan synthase using UDP[6,3H]-glucose as substrate after 60 mins by liquid scintillation counting analysis",CHEMBL,=,,,,,,,,,,Candida albicans
33702,176,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,5.176,Ki,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
185597,3531,559,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",Enzyme,Q08499,PDE4D,PDE4D_HUMAN,9.57,IC50,Inhibition of human PDE4D3 assessed as inhibition of [3H]cAMP hydrolysis to [3H]AMP after 15 mins by scintillation proximity assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
221866,4801,1950,Cyclin-dependent kinase 6,Kinase,Q00534,CDK6,CDK6_HUMAN,6.5,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
170597,1797,3273,Cation channel sperm-associated protein 4,Ion channel,Q7RTX7,CATSPER4,CTSR4_HUMAN,4.5,IC50,"Patch clamp electrophysiology, kinetic rapid mixing fluometry.",IUPHAR,=,,,,,BLOCKER,,Tchem,,,Homo sapiens
218891,5347,736,Ephrin type-A receptor 8,Kinase,P29322,EPHA8,EPHA8_HUMAN,5.11,Kd,Binding constant for EPHA8 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
224058,4947,191,ATP-binding cassette sub-family G member 2,Transporter,Q9UNQ0,ABCG2,ABCG2_HUMAN,4.96,IC50,Inhibition of ABCG2 (unknown origin) expressed in human HEK293 cells membrane vesicles assessed inhibition of BCRP- mediated transport of 3[H]-E1S for 1 mins using [3H]-estrone sulfate as substrate by liquid scintillation counter analysis,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
184955,1175,2877,Phosphodiesterase 7,Enzyme,Q13946|Q9NP56,PDE7A|PDE7B,PDE7A_HUMAN|PDE7B_HUMAN,,,Mechanism of Action; CHEMBL2111411; PROTEIN FAMILY,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200875,INHIBITOR,,Tclin|Tclin|Tclin|Tclin,,,Homo sapiens
185283,2544,823,Ephrin type-A receptor 6,Kinase,Q9UF33,EPHA6,EPHA6_HUMAN,6.02,Kd,Binding constant for EPHA6 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
220101,5405,5012,High affinity immunoglobulin gamma Fc receptor I,Membrane receptor,P12314,FCGR1A,FCGR1_HUMAN,8.15,Kd,Fc-receptor binding,DRUG LABEL,=,1.0,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/761158Orig1s000MultidisciplineR.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/761158Orig1s000MultidisciplineR.pdf,BINDING AGENT,,Tchem,2922.0,2922.0,Homo sapiens
223526,785,186,Transthyretin,Secreted,P02766,TTR,TTHY_HUMAN,5.51,Kd,Binding affinity to TTR V3OM mutant (unknown origin) expressed in Escherichia coli incubated for 60 mins by tryptophan intrinsic fluorescence method,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
164046,1599,316,"Glutamate receptor ionotropic, NMDA 2C",Ion channel,Q14957,GRIN2C,NMDE3_HUMAN,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
217707,5231,2164,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta,Kinase,P78356,PIP4K2B,PI42B_HUMAN,6.57,Kd,Binding constant for full-length PIP5K2B,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
223964,1384,512,"Aspartate aminotransferase, cytoplasmic",Enzyme,P17174,GOT1,AATC_HUMAN,4.83,Ki,Noncompetitive inhibition of GOT1 (unknown origin) using aspartic acid as substrate assessed as inhibition constant by Michaelis-Menten equation based kinetic analysis,CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
187334,2646,667,Bile acid receptor,Nuclear hormone receptor,Q96RI1,NR1H4,NR1H4_HUMAN,5.1,IC50,Antagonist activity at human GTS-tagged FXR after 20 mins by TR-FRET assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
188529,4454,203,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,,,Mechanism of Action; CHEMBL1871; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201101,AGONIST,,Tclin,,,Homo sapiens
220460,5459,669,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,8.7,,,DRUG LABEL,=,,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214622s000lbl.pdf,,INHIBITOR,,Tclin,3223.0,,Homo sapiens
37124,2284,90,Alpha-2A adrenergic receptor,GPCR,P08913,ADRA2A,ADA2A_HUMAN,6.9,Ki,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
215439,1663,314,Aldose reductase,Enzyme,P15121,AKR1B1,ALDR_HUMAN,4.11,IC50,,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
216672,403,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,8.16,IC50,,CHEMBL,=,,,,,,,,,,Rattus norvegicus
218998,4300,2586,Reverse transcriptase,Enzyme,Q9WKE8,reverse transcriptas,Q9WKE8_9HIV1,4.04,IC50,Inhibition of HIV1 RNase H function of recombinant reverse transcriptase using an 18-nt 3'-fluorescein-labeled RNA annealed to complementary 18-nt 5'-dabsyl-labeled DNA as substrate after 10 mins by fluorescence spectrometer analysis,CHEMBL,=,,,,,,,,,,Human immunodeficiency virus 1
38252,3972,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.125,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
37549,2495,144,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,5.863,Ki,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
217729,5231,665,Mitogen-activated protein kinase 8,Kinase,P45983,MAPK8,MK08_HUMAN,5.36,Kd,Binding constant for full-length JNK1,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
186336,2459,2334,Homeodomain-interacting protein kinase 2,Kinase,Q9H2X6,HIPK2,HIPK2_HUMAN,5.77,Kd,Binding affinity to HIPK2,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
184725,1353,2048,Sigma non-opioid intracellular receptor 1,Membrane other,Q60492,SIGMAR1,SGMR1_CAVPO,9.08,Ki,Displacement of [3H](+)-PTZ from sigma1 receptor in Hartley guinea pig brain,CHEMBL,=,,,,,,,,,,Cavia porcellus
164222,1563,213,Carbonic anhydrase 1,Enzyme,P00915,CA1,CAH1_HUMAN,,,,WOMBAT-PK,,,,,,,,Tclin,,,Homo sapiens
224180,2320,843,Voltage-dependent N-type calcium channel subunit alpha-1B,Ion channel,Q00975,CACNA1B,CAC1B_HUMAN,4.85,IC50,Inhibition of endogenous human CaV2.2 in human SH-SY5Y cells in presence of nifedipine by Calcium 4 dye based calcium influx fluorescence-imaging assay,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
224006,464,6770,Sterol regulatory element-binding protein 1,Unclassified,P36956,SREBF1,SRBP1_HUMAN,5.93,IC50,Inhibition of SREBP (unknown origin) expressed in CHO-K1 cells by luciferase reporter assay,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
221426,5493,2577,Orexin receptor type 2,GPCR,O43614,HCRTR2,OX2R_HUMAN,9.03,Ki,Possible mechanism of action,DRUG LABEL,=,,,https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/214985s000lbl.pdf,,ANTAGONIST,,Tclin,3271.0,,Homo sapiens
183324,1187,2422,14-alpha sterol demethylase,Enzyme,Q96W81,cyp51B,Q96W81_ASPFM,5.39,Kd,Binding affinity to Aspergillus fumigatus AF293 sterol 14-alpha demethylase isoenzyme B expressed in Escherichia coli,CHEMBL,=,,,,,,,,,,Neosartorya fumigata
36767,1971,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,6.943,Ki,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DRUG MATRIX,=,,,,,,,,,,Rattus norvegicus
180878,738,161,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,5.04,Ki,Inhibition of full length human CA2 cytosolic isoform by stopped-flow CO2 hydration method,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
27201,2740,105,5-hydroxytryptamine receptor 7,GPCR,P34969,HTR7,5HT7R_HUMAN,6.536,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
186254,1751,1790,Thymidylate synthase,Enzyme,P07607,Tyms,TYSY_MOUSE,4.35,Ki,Inhibitory activity against thymidylate synthase in murine tumor cells,CHEMBL,=,,,,,,,,,,Mus musculus
188710,4713,2133,Serine/threonine-protein kinase 3,Kinase,Q13188,STK3,STK3_HUMAN,5.37,Kd,Binding affinity to MST2,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
183677,1021,1788,Alcohol dehydrogenase [NADP(+)],Enzyme,P51635,Akr1a1,AK1A1_RAT,5.82,IC50,In vitro inhibitory activity against rat kidney aldehyde reductase(ALR).,CHEMBL,=,,,,,,,,,,Rattus norvegicus
219418,568,927,Cytochrome c oxidase subunit 2,Enzyme,P00403,MT-CO2,COX2_HUMAN,6.27,IC50,Inhibition of human COX2 assessed as reduction in PGF2alpha production by ELISA,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
162969,1982,101,5-hydroxytryptamine receptor 2A,GPCR,P28223,HTR2A,5HT2A_HUMAN,8.319,Ki,,WOMBAT-PK,=,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715,ANTAGONIST,,Tclin,,,Homo sapiens
185848,1610,2895,Angiotensin II receptor,GPCR,P30556|P50052,AGTR1|AGTR2,AGTR1_HUMAN|AGTR2_HUMAN,8.43,Kd,Potency to antagonize the ability of angiotensin II to contract rabbit aorta,CHEMBL,=,,,,,,,Tchem|Tclin|Tchem|Tclin,,,Homo sapiens
183332,3042,2617,Thymidylate kinase,Kinase,P9WKE1,tmk,KTHY_MYCTU,5.3,Ki,Inhibition of Mycobacterium tuberculosis recombinant TMPK,CHEMBL,=,,,,,,,,,,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv)
216313,5003,3822,Insulin receptor,Kinase,P15127,Insr,INSR_RAT,8.71,IC50,,CHEMBL,=,,,,,,,,,,Rattus norvegicus
37582,2536,100,5-hydroxytryptamine receptor 1A,GPCR,P08908,HTR1A,5HT1A_HUMAN,6.508,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
163553,852,95,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,4.42,Ki,,WOMBAT-PK,=,,,,,,,Tclin,,,Homo sapiens
188438,4359,2135,NUAK family SNF1-like kinase 2,Kinase,Q9H093,NUAK2,NUAK2_HUMAN,6.66,Kd,Binding constant for SNARK kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
185124,2470,1711,Alpha-1B adrenergic receptor,GPCR,P15823,Adra1b,ADA1B_RAT,8.89,Ki,"Overall binding displacement in tissues containing only the Alpha-1B adrenergic receptor (rat spleen, rat liver)",CHEMBL,=,,,,,,,,,,Rattus norvegicus
37014,2180,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.351,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
183211,1988,353,Arachidonate 5-lipoxygenase,Enzyme,P09917,ALOX5,LOX5_HUMAN,,,Mechanism of Action; CHEMBL215; SINGLE PROTEIN,CHEMBL,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL425,INHIBITOR,,Tclin,,,Homo sapiens
34135,522,107,Alpha-2B adrenergic receptor,GPCR,P18089,ADRA2B,ADA2B_HUMAN,7.367,Ki,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
187478,4120,1996,Metabotropic glutamate receptor 6,GPCR,P35349,Grm6,GRM6_RAT,5.57,EC50,Concentration for half maximal activation of metabotropic glutamate mGluR6 in rat,CHEMBL,=,,,,,,,,,,Rattus norvegicus
27752,1524,290,5-hydroxytryptamine receptor 1F,GPCR,P30939,HTR1F,5HT1F_HUMAN,8.903,Ki,,PDSP,=,,,,,,,Tclin,,,Homo sapiens
222027,5259,2354,Serine/threonine-protein kinase TAO3,Kinase,Q9H2K8,TAOK3,TAOK3_HUMAN,5.76,Kd,"Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.",CHEMBL,=,,,,,,,Tbio,,,Homo sapiens
215483,1239,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,5.79,Ki,,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
220117,5416,1716,Melanocortin receptor 4,GPCR,P32245,MC4R,MC4R_HUMAN,8.68,Kd,Mechanism of Action,DRUG LABEL,=,1.0,DRUG LABEL,https://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/213793Orig1s000ClinPharmR.pdf,https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213793Orig1s000RPLlbl.pdf,AGONIST,1.0,Tclin,2944.0,2943.0,Homo sapiens
219451,1637,703,Estradiol 17-beta-dehydrogenase 1,Enzyme,P14061,HSD17B1,DHB1_HUMAN,5.26,IC50,"Inhibition of human 17beta-HSD1 expressed in HEK293 cell lysates incubated for 10 mins using [2,4,6,7-3H]-estrone and NADPH by scintillation counting method",CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
219715,3514,4521,"Solute carrier family 2, facilitated glucose transporter member 2",Transporter,P11168,SLC2A2,GTR2_HUMAN,4.92,IC50,Inhibition of human GLUT2 expressed in Xenopus laevis oocytes assessed as reduction in [14C]fructose uptake by scintillation spectrometric method,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
35270,977,99,Sodium-dependent noradrenaline transporter,Transporter,P23975,SLC6A2,SC6A2_HUMAN,6.341,Ki,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
215095,5109,334,Plasminogen,Enzyme,P00747,PLG,PLMN_HUMAN,,,Mechanism of Action,DRUG LABEL,,1.0,DRUG LABEL,,http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021846s101lbl.pdf,ACTIVATOR,,Tclin,,580.0,Homo sapiens
162652,847,176,Kappa-type opioid receptor,GPCR,P41145,OPRK1,OPRK_HUMAN,,,,WOMBAT-PK,,1.0,CHEMBL,,https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1685,ANTAGONIST,,Tclin,,,Homo sapiens
188446,4359,2230,Dual specificity mitogen-activated protein kinase kinase 6,Kinase,P52564,MAP2K6,MP2K6_HUMAN,5.89,Kd,Binding constant for MEK6 kinase domain,CHEMBL,=,,,,,,,Tchem,,,Homo sapiens
170601,2162,563,Glycine receptor subunit beta,Ion channel,P48167,GLRB,GLRB_HUMAN,4.5,IC50,,IUPHAR,=,,,,,BLOCKER,,Tclin,,,Homo sapiens
220804,4875,4558,Nonstructural protein 5A,Unclassified,Q5L478,NS5A,Q5L478_9HEPC,10.64,IC50,Inhibition of NS5A in HCV genotype 1b infected in human HuH7.5/Con1/SG-Neo(I)-hRluc2aUb cells assessed as inhibition of replicon levels incubated for 72 hrs by luciferase reporter gene assay,CHEMBL,=,,,,,,,,,,Hepatitis C virus
37586,2536,108,D(3) dopamine receptor,GPCR,P35462,DRD3,DRD3_HUMAN,6.146,Ki,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DRUG MATRIX,=,,,,,,,Tclin,,,Homo sapiens
182396,518,66,Prostaglandin G/H synthase 1,Enzyme,P23219,PTGS1,PGH1_HUMAN,4.88,IC50,Inhibitory activity against cell-free canine COX-1,CHEMBL,=,,,,,,,Tclin,,,Homo sapiens
35499,1043,50,5-hydroxytryptamine receptor 4,GPCR,O70528,HTR4,5HT4R_CAVPO,6.578,Ki,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),DRUG MATRIX,=,,,,,,,,,,Cavia porcellus
185853,1273,2051,Muscarinic acetylcholine receptor M2,GPCR,P06199,CHRM2,ACM2_PIG,6.89,EC50,Inhibition of [3H]NMS dissociation from porcine muscarinic M2 receptor,CHEMBL,=,,,,,,,,,,Sus scrofa
216654,1200,1732,Alpha-1A adrenergic receptor,GPCR,P43140,Adra1a,ADA1A_RAT,5.96,IC50,,CHEMBL,=,,,,,,,,,,Rattus norvegicus
27007,3170,114,Muscarinic acetylcholine receptor M2,GPCR,P08172,CHRM2,ACM2_HUMAN,4.2,Kd,,IUPHAR,=,,,,,ALLOSTERIC MODULATOR,,Tclin,,,Homo sapiens
